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Abstract
Background: Heart Failure (HF) disease management programs (DMP) have shown to
improve outcomes. The aim of this heart failure pilot program is an evaluation program.
Measurement of functional capacity utilized the Duke Activity Status Index (DASI)
questionnaire. Since the DASI uses the patient’s ability to perform a set of common activities of
daily living to gauge functional capacity based on the known metabolic cost of each activity in
MET units, it is thought to be well suited for population studies in which assessment of
functional capacity during follow-up is needed.
Setting: Rural Critical Access Hospital (CAH) with outpatient cardiology services.
Methods: This HF pilot is a program evaluation which involved a one group, pre-test
and post-test design. Five additional variables were analyzed to determine if any relationship
occurred with O2 uptake change as noted in changes in DASI. The five variables included key
items for the pilot program: HF education, teach back method, inpatient nutrition consult, DC
time out, and follow-up with a Nurse Practitioner (NP).
Results: There were a total of 17 patients who received the inpatient pilot program
throughout their hospital stay until discharging home. Eleven of the 17 patients benefitted from
the entire program (inpatient & outpatient) with continued care in the outpatient cardiology
department. Thirteen patients completed the inpatient and outpatient Duke Activity Status Index
(DASI). Paired T-Test was conducted to compare inpatient vs. outpatient of O2 uptake. There
was no significant difference in scores for inpatient (M = 20.99, SD = 6.42) and outpatient (M =
19.26, SD 5.28), t (12) = .94, p = .36 (two-tailed). Wilcoxson Signed Rank Test, non-parametric
test of differences, demonstrated no statistical difference between inpatient and outpatient
oxygen (O2) uptake; [z = -.839a, p = .40]. An independent-samples t-test was conducted to
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compare O2 uptake changes based on gender. Difference between males’ and females’ ages was
not statistically significant (p = .403; two-tailed). Pearson correlation or Spearman correlation
was used to give the direction and strength of the relationship between variables. A moderate
correlation was detected with age and O2 uptake change from outpatient vs inpatient, (p < 0.05).
An independent-samples t-test was conducted to compare O2 uptake changes based on age.
Average O2 uptake decreased by 7 for patients 70 or under (M = 7.00, SD = 4.82), and increases
by 3 for those over 70 (M = 2.77, SD = 4.19); t (11) = 3.91, p = < 0.01. Explanations for this
inverse detection are multi-factorial.
Five pilot program variables were analyzed to determine if any relationship occurred with
O2 uptake change as noted in changes in DASI. “Teach back method” demonstrated that two
patients were unable (M = 7.5, SD = 5.16); 11 patients were able (M = -3.41, SD = 5.49); (t (11)
= 2.60, p = .024 [two tailed]). This is statistically higher at p < 0.05. Especially surprising about
this result is that average O2 uptake change of 7.5 for 2 patients who were “unable to teach
back” is significantly higher, than average O2 uptake change of -3.4 for 11 patients who were
“able to teach back”. The scores of the 2 patients that “were unable” went up, while those that
“were able”, went down on average.
Conclusion: The usefulness for clinical decision making regarding lower O2 uptake
scores for those under 70 compared those over 70 cannot be fully described or understood given
the nature of this result. The fact that other clinical factors are also independent predictors of
functional capacity indicates that an uncomplicated course of inpatient heart failure designated
care is not, in of itself, sufficient to guarantee an optimal functional outcome. This particular
notion may also be apparent within the “teach-back” variable and O2 uptake change.
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TRANSITIONS HOME FOR PATIENTS WITH HEART FAILURE: A PILOT PROGRAM
AT A CRITICAL ACCESS HOSPITAL
Problem Identification
Hospitals and health care systems are focusing on improving performance and patient
outcomes in cardiovascular services, with a particular focus on heart failure (HF). There is great
interest in which aspects of HF management can prevent readmissions, decrease the cost per
case, and improve the quality and satisfaction for this particular patient population (Hines, Yu, &
Randall, 2010). The June 2007 and 2008 Medicare Payment Advisory Commission (MedPAC)
Reports to Congress highlighted avoidable re-hospitalizations as an area of high cost and low
quality (Boutwell, Jencks, Nielsen, & Rutherford, 2009, p. 2). According to Boutwell, Jencks
and colleagues (2009), these reports have prompted leaders of health care systems across the
country to begin to focus on avoidable re-hospitalizations in anticipation of potential changes in
the healthcare market.
In a rural 25 bed Critical Access Hospital (CAH), quality data for fiscal year 2005
demonstrated that the CAH provided recommended HF care 79% of the time (Massachusetts
Health Care Quality and Cost Information, 2006). The recommended care is a nationally
recognized set of measures known as “Core Measures” (Joint Commission [JC], 2010), or
guidelines, which identify the treatments a HF patient should receive (Massachusetts Health Care
Quality and Cost Information, 2006). More recent data, however, demonstrates improvement in
appropriate care with results fluctuating between 81% - 100% (Figure 1 & 2). Specific
performance concerns at this CAH regarding HF appropriate care reside specifically within
smoking cessation and discharge instruction measurements (Figure 1 & 4).
Statement of Problem.
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Issel’s (2004) model for problem definition was used to construct the problem statement.
The problem is stated as: Increased frequency of hospital readmissions among adult patients, >
18 yrs. of age, with exacerbation of known heart failure condition; as indicated by increased
number of "same or similar" coded hospital admissions for same patients. These rehospitalizations are related to de-compensating physiological processes, given existing
vulnerable health, co-morbidities, and specific health practices. It is assumed that the rehospitalizations are influenced by a lack of adequate primary care clinician teaching and regular
follow up regarding disease management / prevention and the patients' own health behaviors.
Avoiding HF re-hospitalizations requires identification and mitigation of barriers to
system-wide improvement, and coordination across the continuum of care (Institute for
Healthcare Improvement [IHI], n.d.). On May 1, 2009, IHI launched STate Action on Avoidable
Re-hospitalizations (STAAR) a multi-state, multi-stakeholder approach aimed to improve the
delivery of effective HF care at a regional scale (IHI, n.d.). Other IHI initiatives to improve
transitions and reduce readmissions includes Improving Transitions in Care Collaborative which
focuses on creating an ideal transition for patients from the hospital to home with an aim to
reduce 30-day readmission rates by 30 percent and increase patient and family satisfaction with
optimal transitions and coordination of care (IHI, n.d.). This Critical Access Hospital 30-day allcause HF readmission rate for 2010 is 11.76%, up from 2.38% in 2009 (Figure 3).
The Centers for Medicare & Medicaid Services (CMS) included a Care Transitions focus
in its 9th Statement of Work, which started in 2008. As a result, Quality Improvement
Organizations (QIOs) in 14 communities are now working to coordinate care and improve
transitions with the specific aim of reducing re-hospitalizations (Boutwell, Jencks et al., 2009).
Although there is currently no nationally adopted re-hospitalization measure, Boutwell, Jencks
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and colleagues suggest that a number of states are preparing to publicly report 30-day rehospitalization rates.
Evidence of Problem.
As previously stated, the hospital current 30-day all-cause HF readmission rate is
11.76%, a notable increase of over 9% since 2009. Success in improving transitions of care and
reducing avoidable re-hospitalizations requires engaging clinicians and providers across the
organization and service delivery types (Boutwell, Jencks et al., 2009). Reducing rehospitalizations in a state or region will require coordinated effort among providers and
organizations that lack financial and perhaps information-sharing relationships. Finally, the
participation and engagement of patients and families is essential to improving coordination of
care and accessing care at the right time, in the right place, that serves the needs of the individual
(Boutwell, Jencks et al., 2009).
Results of Needs Assessment.
In a more narrowly defined, traditional sense, a needs assessment is the means by which
one determines the gaps, lacks, and wants relative to a defined population and a defined, specific
health problem (Issel, 2004, p. 121). The gap at the Critical Access Hospital (CAH) consists of a
lack of a formal HF inpatient and outpatient program. Another hospital affiliate has a formal
inpatient and outpatient HF program; yet it may be difficult for patients to access their outpatient
program based on location and distance. Estimated mileage from the CAH to the affiliate
hospital is approximately 21.8 miles; minimum of 38 minutes due to traffic. This estimate does
not include areas south from the CAH. Furthermore, a majority of patients seeking HF care at
the CAH are greater than 60 years old and have Medicare as their primary insurance; driving
21.8 miles north, or more, may be a difficult and daunting endeavor for this population group.
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Prior to the start of the pilot project, every HF patient at the CAH received a HF
education packet which included a HF book describing key factors in living with HF and
symptom management. However, there was no system in place to document patient or caregiver
understanding based on the education packet. Given the fluctuation in outcome measures for HF
discharge instructions, opportunities for improvement existed in closing various gaps by ensuring
all HF patients receive adequate and appropriate education and discharge instructions by a
designated HF nurse.
Evidence of Stakeholder Support and Letter of Agreement
Critical Access Hospital (CAH). The primary stakeholders and/or key persons for this
HF pilot program are based at the CAH and included the following: Vice President (VP) of
Operations/Chief Nursing Officer (CNO); Chief of Medical Staff; Executive VP/Chief Financial
Officer (CFO); Chairman of the Hospitalist Program; Medical Director of the Quality
Management Department along with quality staff members; two Cardiologist’s and NP in the
outpatient Cardiology Department; outpatient Cardiology Department staff; Cardio-Pulmonary
Registered Nurse who served as the program assistant to the program facilitator for this HF pilot;
HF Nurses from Med-Surgical Unit (2MS) and CCU (total of 24 HF nurses); Case Management
Department; and the Dietary Department.
Affiliate Hospital. Nurse Practitioner in the Cardiology Department located north of the
CAH agreed to participate in this project by capturing HF patients who lived near the CAH by
administering the pilot program while inpatient and then scheduling the same patient for
outpatient cardiology services at the CAH.
Evidence of Agreement. On file with CEO/CNO at the CAH and at UMass, Amherst
doctoral nursing faculty. The support of all these stakeholders was invaluable during the course
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of this HF pilot. Each person and department listed proved to be instrumental to the overall
success of this HF pilot project.
Evidence of the problem demonstrated in the literature.
According to Chan and colleagues (2008) disease management programs aim to address
the barriers to successful treatment by patient education and multidisciplinary coordination.
Poor discharge processes, lack of timely follow-up, uncertainty regarding self-management
tasks, and confusions about medications all result in highly variable care at times of transitions
and impact a large proportion of HF patients (Boutwell, Jencks et al., 2009).
Goals / Objectives.
This CAH HF Pilot Program will focus on patient education, assessment of
understanding HF disease management, and follow-up through a multidisciplinary approach to
coordination of care. This pilot includes designated HF nurses, Hospitalists involvement, post
discharge phone follow-up by the program facilitator or program assistant, and outpatient
intervention by an experienced Cardiology Nurse Practitioner. The goal was to implement this
pilot with all HF admissions during the pilot timeframe of January 1, 2011 through March 31,
2011.
The overall long term outcome measures of success with the HF pilot program focused
on readmission rates and mortality (Taylor, Bestall, Cotter, Falshaw, & Hood et al., 2009).
Specific pilot program outcome measures are described under Program Goals for Specific
Outcome Indicators: Table II – V of this paper.
Review of Literature
Heart Failure (HF) affects nearly six million people in the United States, with about
670,000 people being diagnosed with it each year (Centers for Disease Control and Prevention
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[CDC], 2010). In 2010, HF will cost the United States 39 billion dollars which includes the cost
of health care services, medications, and lost productivity (CDC, 2010). Hospitals and health
care systems are focusing on improving performance and patient outcomes in cardiovascular
services, with a particular focus on how the management of HF can prevent readmissions,
decrease the cost per case, and improve the quality and satisfaction for this particular patient
population (Hines, Yu, & Randall, 2010).
Heart Failure is a complicated disease which requires lifestyle modifications involving
complex medication regimens, ensuring adequate exercise and dietary discretion, and keeping a
close eye on daily weights (White, Howie-Esquivel, & Caldwell, 2010). The majority of HF
care is performed at home by the patient and family or caregiver, however if these individuals do
not know what is required, fail to see its importance, or face barriers to engagement in self-care,
they will not participate effectively (Lindenfeld, Albert, Boehmer, Collins, Ezekowitz et al.,
2010). While this concept is understood among healthcare providers, there is evidence
suggesting that patients themselves remain unclear about their role in managing this disease
(White et al., 2010; Chan, Heidenreich, Weinstein, & Fonarow, 2008).
A recent study by Jencks, Williams, and Coleman (2009) investigated Medicare claims
data from 2003-2004 in order to describe the patterns of re-hospitalizations and characteristics of
hospitals. In the case of 50.2% of the patients who were re-hospitalized within 30 days after a
medical discharge to the community, there was no bill for a visit to a primary care or specialty
physician’s office between the time of discharge and re-hospitalization (Jencks et al., 2009).
Conducting a literature review to evaluate evidence regarding intervention strategies in
HF and disease management may provide meaningful evidence leading to specific changes in HF
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interventions prior to discharging patients from the hospital to home; thus, reducing future
readmissions (Willey, in press).
A comprehensive search of the literature for HF and disease management evidence
included the following databases: PubMed of the National Library of Medicine, Cochrane, and
Cumulative Index of Nursing and Allied Health Literature [CINAHL]. The following MeSH
terms were used for the PubMed search: “heart failure” (HF) and “disease management” (DM)
and “randomize [publication type]”; however, the third term was alternated in PubMed to include
an additional MeSH search term, “meta-analysis”. The Cochrane search terms for the MeSH
descriptor included: “heart failure” exploding all trees with qualifier “Nursing”. Additionally,
the Cochrane Database of Systematic Reviews listed 18 studies for HF. The following terms
used in CINAHL included: “heart failure” and “disease management” with third terms
alternating from randomized controlled trials, meta-analysis, and prospective randomized study.
Disease management (DM) is defined within PubMed MeSH term as a broad approach to
appropriate coordination of the entire disease treatment process that often involves shifting away
from more expensive inpatient and acute care to areas such as preventive medicine, patient
counseling and education, and outpatient care (Woodward, 1995). This concept includes
implications of appropriate versus inappropriate therapy on the overall cost and clinical outcome
of a particular disease.
Seventy-two articles were retrieved from the search of the above databases using the
selected MeSH terms and accessing the Cochrane Database of Systematic Reviews. Inclusion
criteria consisted of full-text articles published in the English language. Due to the rapidly
changing evidence in HF research, studies were identified only from the last 6 years (2005 2010). Of these, one was a duplicate, one was non-English, one was expert opinion regarding a
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previous RCT study, numerous studies combined HF interventions with other disease states, one
study displayed conflicts of interest, two studies were on-going with pending results, two studies
failed to include sample size and/or statistical results, one study focused on public policy, and
one study demonstrated questionable inclusion criteria. Also excluded were two studies which
duplicated one another without focusing on specific HF interventions, one study was descriptive
with 13 subjects from a parent RCT study; and seventeen were conducted prior to 2005. In
summary, of 72 articles, 53 had to be eliminated leaving 19 studies to be examined (See
Appendix A). Discussion of studies follows herein.
Telephonic Monitoring and Telephone Interventions
Copeland and colleagues (2010) assessed the effects of a telephone intervention which
included access to a nurse advice line for symptoms and counseling 24 hours a day 7 days per
week, medication compliance reminders, fluid weight management, diet, scheduled nurse
education, vital signs monitoring, early treatment for escalating symptoms, along with faxed
alerts being sent to the participant’s physician about signs and symptoms of decompensation.
Results demonstrated modest improvement in weight monitoring and physical well-being with
higher total costs of care, but no survival benefit. However, the intervention may have prompted
needed medical service utilization by facilitating access to care, resulting in higher costs of care,
including outpatient and HF related care costs.
Findings from the randomized, intent-to-treat design conducted by Esposito and fellow
investigators (2008) in a population-based program providing primarily telephonic patient
education and monitoring services showed virtually no overall impact on hospital or emergency
room use, quality of care, or prescription drug use for the 33,000 enrollees. However, for
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beneficiaries with HF who resided in high-cost South Florida counties, the program reduced
Medicare expenditures by 9.6 percent.
Ramachandran and fellow researchers (2007) demonstrated significant improvement with
telephonic helpline access along with regular telephone calls reinforcing HF information and
modification of drug dosages. Results demonstrated improvements in functional capacity
measured by the 6-minute walk test (p <0.05), drug therapy with beta-blockers (p <0.05), and a
larger number of patients improved in NYHA functional class (p <0.004). There were no
significant differences in the number of emergency room visits or admissions in either group.
Furthermore, these researchers suggest that their results may be due to cultural conditioning in
the setting of a developing country which may not work in other geographical areas and may
need to be adapted to local environments.
Riegel and colleagues (2006) tested the effectiveness of telephone case management in
decreasing hospitalizations and improving health-related quality of life (HRQL) and depression
in Hispanics of Mexican origin with HF. While HF DM may be effective in other population
groups, findings from this study suggest that a different approach may be needed in Hispanics
since no statistical differences were found in HF readmission rates, HF days in the hospital, HF
cost of care, all-cause hospitalizations or cost, mortality, HRQL, or depression.
A literature review which was located outside of the mesh term search yet is worthy of
inclusion since the primary purpose was to examine advanced practice nurse (APN) directed
versus registered nurse (RN) directed telemanagement programs for HF patients. According to
Delgado-Passler and McCaffrey (2006) research findings from three RCTs confirm establishing
the APN role as an effective approach since APNs are able to change medication and dosages,
order outpatient testing, and were better educated in the pathophysiology of HF; thus, reducing
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frequent hospitalizations. Outcomes from all three RCTs demonstrated statistically significant
results in re-hospitalization rates with APN directed telemanagement care (p < 0.05).
While the efficacy of structured telephone support or telemonitoring as a successful
individual component of a HF program remains inconclusive as noted with various RCT findings
included in this review, the systematic review conducted by Inglis and colleagues (2010) metaanalyzed 25 peer-reviewed studies: 16 evaluated structured telephone support (5613
participants), 11 evaluated telemonitoring (2710 participants), and two tested both interventions
(included in counts). Results demonstrated the following: telemonitoring reduced all-cause
mortality (p < 0.0001) with structured telephone support demonstrating a non-significant positive
effect (p = 0.08); all-cause hospitalization data revealed that structured telephone support was
effective in reducing the risk of all-cause hospitalizations in patients with HF (p = 0.02), as was
telemonitoring (p = 0.02); both structured telephone support (p < 0.0001) and telemonitoring (p
= 0.008) reduced HF-related hospitalizations.
This systematic review provides further confirmation of the efficacy of structured
telephone support and telemonitoring interventions as an effective component of contemporary
multidisciplinary HF management (Inglis et al., 2010). However, Inglis and fellow researchers
suggest that future use of structured telephone support and telemonitoring should be to use these
interventions tailored to HF DM programs, population needs including geography of the
population, available resources and most importantly, to patient preferences. In addition, these
researchers suggest that more work is required on the business models underlying the costeffectiveness of telemonitoring in particular.
Implantable Hemodynamic Monitoring
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The safety and efficacy of the use of an implantable hemodynamic monitor (IHM)
management strategy to reduce the rate of heart failure related events (HFRE) in patients with
diastolic heart failure (DHF) who were already receiving optimal medical care in a HF DM
program, was analyzed by Zile and colleagues (2008). Patients included in the DHF subgroup
were previously described in the COMPASS-HF trial (Bourge et al., 2008) and had New York
Heart Association (NYHA) Class III or IV HF, and were managed in a HF program with
optimized standard medical therapy for at least 3 months before enrollment (Zile et al., 2008).
Data presented in this subgroup of 70 DHF patients support the following conclusions:
IHM was shown to be safe and was associated with a very low system-related and procedurerelated complication rate in DHF patients, and within the context of the limited power of this
subgroup analysis, IHM-guided care did not result in a statistically significant reduction in HFRE
rate or reduction in relative risk of a HFRE in DHF patients (Zile et al., 2008). Similar finds
were found in the COMPASS-HF study which demonstrated that the IHM guided care did not
significantly reduce total HF-related events compared with optimal medical management
(Bourge et al., 2008).
Heart Failure Disease Management Programs
Seven RCT studies evaluated the effectiveness of heart failure disease management (HF
DM) programs with three studies evaluating the effectiveness of a nurse-led disease management
program (Hebert et al., 2008; Jaarsma et al., 2008; Krantz et al., 2008). Hebert and fellow
researchers (2008) demonstrated better physical functioning throughout the 12-month nursemanaged intervention, except for out-patient procedures, which were more costly in the nursemanaged group. This trial was conducted in an ethnically diverse, inner-city neighborhood and
may not be generalized to other settings.
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Jaarsma and colleagues (2008) demonstrated no benefit of a nurse-led management
program 18 months after hospital discharge. Findings demonstrated a slight increase in the
number of short hospitalizations yet it is unclear how many of those patients were severely ill.
Furthermore, it is unclear what the criteria for admission entailed, pointing to possible low
thresholds for re-hospitalization.
Krantz and affiliates (2008) compared 6-month re-hospitalization rates among patients
assigned to pre-discharge B-blockade coupled with post-discharge nurse management
(intervention) versus usual care. Results demonstrated at 6 months, B-blocker utilization was
higher (p = < .001), mean NYHA class improved (p = .01), and total HF re-hospitalizations were
reduced by 84% (p = .02), a trend toward improved LVEF was also observed. This study
suggests that pre-discharge B-blocker initiation coupled with nurse follow-up improves
outcomes among HF patients with LV systolic dysfunction. However, since these researchers
used a hybrid treatment strategy combining both medication initiation and nurse follow-up, it is
impossible to quantify the contribution of each program component to the observed improvement
in outcomes.
The remaining four RCTs evaluated the effectiveness HF DM programs (Nguyen et al.,
2007; Del Sindaco et al., 2007; Nucifora et al., 2006; Ojeda et al., 2005). Nguyen and fellow
investigators (2007) assessed the long-term impact on the number of recurrent hospital
admissions, ED visits, and mortality after a 6-month course in a HF DM program. After a mean
follow-up of 2.8 + 1.7 years, there was no difference in all-cause death, hospital admissions, and
ED visits between those patients initially in the HF management program group and the controls.
After multivariable adjustment, there was no difference in all-cause death alone between those
initially assigned to the HF clinic and those receiving usual care.
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Del Sindaco and colleagues (2007) studied the long-term effects of a hybrid DMP
involving cardiologists, primary care practitioner’s (PCPs) and nurses in older HF outpatients
aged > 70. Results demonstrated that the DMP was associated with a 42% relative risk reduction
of an unplanned hospital admission due to HF, 25% fewer patients with at least one hospital
admission for any reason, length of hospital stay for all causes or HF admission was significantly
shorter in the DMP group (p = 0.0025), and a 36% reduction in all-cause death.
Nucifora and fellow researchers (2006) evaluated effects of a HF management program
which included patient education, regular outpatient contact with a HF nurse, and outpatient
visits with an internal medicine doctor planned at 15 days, 1 and 6 months after discharge.
Results demonstrated no difference in the rate of symptom improvement, hospital readmissions,
or hospital discharge to death between the intervention and control groups. Additionally,
unplanned outpatient visits were fewer in the intervention group (p < 0.001) with the mean
number of unplanned outpatient visits per patient was 0.4 + 0.9 in the intervention group and 1.0
+ 1.3 in the control group (p < 0.001). These results suggest that in order to reduce the number
of hospital admissions for HF patients, a more intensive and long-term intervention may be
needed than what was adopted in this HF management program study.
Ojeda and fellow investigators (2005) evaluated whether improvements obtained during
an HF intervention program were maintained after an average period of 16 + 8 months when the
intervention was stopped. During the 16 + 8 month treatment period, patients in the intervention
group had a lower rate of HF readmissions (17% vs. 51%, p < 0.01) and less all-cause mortality
(13% vs. 27%, p= 0.03). One year after stopping the intervention, there was no difference in HF
readmissions (28% vs. 25%, p= 0.72) or all-cause mortality (14% vs. 17%, p= 0.64). Thus, the
positive effects of a HF program were clearly reduced when it was stopped.
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Two of the meta-analysis studies evaluated effects of Disease Management Programs
(DMPs) on HF clinical outcomes (Gohler et al., 2006; Roccaforte et al., 2005). Results
demonstrated that DMPs have the potential to reduce morbidity, mortality, and hospitalizations
in HF patients. Both studies found a substantial reduction in the rates of all-cause hospital readmissions and HF-related hospitalizations.
Gohler and colleagues (2006) conducted a systematic literature search on RCTs
investigating the effect of DMPs on HF outcomes and performed meta-analyses and metaregressions comparing DMPs and standard care for mortality and re-hospitalization. Their metaanalysis of 36 RCTs for a total of 8,341 patients yielded a statistically significant pooled
differences in the following: first all-cause re-hospitalization of 8% (95% CI 5-11%, p < .0001),
subsequent all-cause re-hospitalizations of 19% (95% CI 2-35%, p < .0001), and a statistically
significant pooled mortality difference of 3% (95% CI 1-5%, p < .01); all favoring DMPs over
standard care.
Similarly, Roccaforte and fellow researchers (2005) conducted a systematic literature
search on RCTs investigating the effect of DMPs on HF outcomes and performed meta-analyses.
This study also explored whether specific types of DMPs, or different components, timing and
duration of the program, were likely to be most beneficial. Results from 33 RCTs demonstrated
that mortality was significantly reduced by a DMP compared to usual care (p = 0.003), all-cause
and HF-related hospitalization rates were also significantly reduced (p = 0.00001) respectively.
In addition, different DMP approaches appeared to be equally effective as observed across
several sensitivity analyses. According to Roccaforte and colleagues, in high quality studies and
programs lasting 3-6 months, findings were most consistently associated with a significant
reduction in all outcomes considered. These researchers concluded that a comprehensive DM
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program for HF patients reduced mortality and hospitalizations and are potentially cost-saving in
moderate to high risk populations.
In contrast, the objective of Phillips and fellow researchers (2005) meta-regression
analysis was to determine whether a hierarchy of effectiveness exists with respect to published
protocols of HFDM incorporating specialist nurse-led HF clinics. These researchers reviewed
and deconstructed published protocols from randomized trials of HFDM with specialist nurse-led
HF clinics. Meta-regression analysis was conducted to study the relationship between
differences in complexity of intervention and readmission rate, mortality, the combined endpoint
of mortality and hospitalization, HF readmission, the number of hospital days utilized per patient
during follow-up, quality of life (QOL), and cost of care. They reported that complex programs
that included hospital discharge planning and no delay in post-discharge clinic follow-up were
the most successful showing a trend towards 70% relative reduction in risk for first readmission,
two fewer hospital days utilized per patient per readmission (p = 0.02), and a 70% reduction in
risk of HF readmission relative to usual care (p = 0.01). Less complex programs did not impact
readmission or hospital days utilized during follow-up relative to usual care.
The systematic review conducted by Yu and colleagues (2006) indicated that DMPs are
effective in ameliorating poor discharge outcomes. The purpose of the systematic review was to
identify the characteristics of DMPs which are crucial to reducing hospital readmission and/or
mortality of hospitalized elderly HF patients. Their results suggest that an effective DMP should
be multi-faceted and consists of an in-hospital phase of care built into the DMP with care
focused on intensive patient education, self-care supportive strategies, exercise, and psychosocial
counseling along with developing a post-discharge plan to address the individualized risk factors
of poor discharge outcomes.
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Finally, the objective in the systematic review by Taylor and fellow researchers (2009)
was to assess the effectiveness of DM interventions for patients with HF. These researchers
classified interventions from 16 trials involving 1,627 patients into three models:
multidisciplinary interventions (a holistic approach bridging the gap between hospital admission
and discharge home delivered by a team); case management interventions (intense monitoring of
patients following discharge often involving telephone follow up and home visits); and clinic
interventions (follow up in a HF clinic). Conclusions from this review demonstrated the
following: the single RCT of a multidisciplinary intervention showed reduced HF related
readmissions in the short term with little evidence to support clinic based interventions; case
management tended to be associated with reduced all cause mortality but these findings were not
statistically significant (p = 0.23), although the evidence was stronger when analysis was limited
to the better quality studies (p = 0.04), there was weak evidence that case management
interventions may be associated with a reduction in admissions for HF and unclear what the
effective components of the case management interventions are; no evidence of any benefit from
clinic interventions due to the lack of sufficient evidence and statistical power. The data
abstracted from this review does not allow formulation of firm recommendations for practice.
This literature search revealed HF and DM MeSH terms resulted in several studies linked
specifically to DMPs. However, HF DM programs vary in their content as demonstrated in this
review which is further supported within the American College of Cardiology and American
Heart Association (ACC/AHA) Guidelines for the Diagnosis and Management of Heart Failure
in Adults (Hunt et al., 2009). Findings from the RCTs on HF DM do not allow one to draw
strong conclusions about the benefits of various HF DM interventions because they were
different in structure, content and intensity. Several factors may have contributed to these
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findings including sample size, intervention features vary from one DMP to another, usual care
(the control group) was poorly defined and described or not described at all, and length of
follow-up may not capture all long term effects. In addition, according Gohler and colleagues
(2006) due to the nature of DMPs, blinding of patients and care providers to the intervention is
not possible. Ultimately, that particular aspect may result in bias during a subjective assessment
of outcomes (Melnyk & Fineout-Overholt, 2005).
A systematic reviews or meta-analysis of available evidence regarding any problem or
solution contains information representative of multiple studies distilled into a succinct summary
derived from the synthesis of the evidence and authors include specific details that demonstrate
the strength of the evidence with the strongest level of evidence graded as Level l. Because
Level 1 studies combines the samples of each study included in the review to create one larger
study, the summary statistic is more precise than the individual findings from any one of the
contributing RCT studies alone (Melnyk & Fineout-Overholt, 2005). Results of this review from
Level 1 evidence demonstrated positive benefits from heart failure disease management (HF
DM) programs, structured telephone support, and telemonitoring interventions as an effective
component of contemporary multidisciplinary HF management (Inglis et al., 2010; Gohler et al.,
2006; Yu et al., 2006; Roccaforte et al., 2005).
Two meta-analyses (a meta-analysis is a form of retrospective research or investigation)
demonstrated that DMPs reduced mortality and hospitalizations in HF patients (Gohler et al.,
2006; Roccaforte et al., 2005) with one meta-regression analysis suggesting that specialist nurseled HF clinics are a promising alternative and an appealing strategy for selected patients (Phillips
et al., 2005). Multidisciplinary care teams with an effective structure, using a wider range of
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expertise, were found to be most effective in addressing the complex heath care needs of HF
patients (Gohler et al., 2006).
A widely accepted method and simple metric is The New York Heart Association
(NYHA) classification system that grades heart failure I through IV, based on the extent of
dyspnea and fatigue which is experienced and reported by the patient (Delgado-Passler &
McCaffrey, 2006). The majority of patients who have recurrent and frequent hospitalizations
belong to either class III or class IV, yet without including this classification, it is difficult to
gauge response to therapy (Lindenfeld et al., 2010). According to Lindenfeld and colleagues,
therapeutic recommendations often are directed toward patients within particular NYHA classes,
thus functional capacity/activity level and severity of clinical disease should be evaluated and
recorded based on the HYHA functional classification for all HF patients. Success of therapy
may be indicated by improvement of at least 1 functional class.
Finally, another classification system developed in 2001 by the American College of
Cardiology and the American Heart Association (ACC/AHA) Task Force on Practice Guidelines
emphasized the classification of HF based on development and progression of the disease (Hunt
et al., 2009). They identified 4 stages involved in the development of the HF syndrome with the
first two stages (A and B) not being HF, but are an attempt to help healthcare providers with the
early identification of patients who are at risk for developing HF (Hunt et al., 2009). Stage C
denotes patients with current or past symptoms of HF (the bulk of patients with HF), and Stage D
designates patients with truly refractory HF who may be eligible for specialized and advanced
treatment strategies (Hunt et al., 2009). This classification system, according to Hunt and
colleagues (2009), is intended to complement but in no way replace the NYHA functional
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classification, which primarily gauges the severity of symptoms in patients who are in Stage C or
Stage D.
Implications of the Evidence Review
Findings from this critique demonstrated positive benefits from heart failure disease
management (HFDM) programs, structured telephone support, and telemonitoring interventions
as an effective component of contemporary multidisciplinary HF management (Inglis et al.,
2010; Gohler et al., 2006; Yu et al., 2006; Roccaforte et al., 2005), yet building a clinical case for
HF programs requires cost monitoring and revenue analysis which are important in
demonstrating the business case for HFDM programs and/or interventions (Hines, Yu & Randall,
2010; Inglis et al., 2010).
Heart Failure is a syndrome rather than a primary diagnosis with many potential
etiologies, diverse clinical features, and numerous clinical subsets (Lindenfeld et al., 2010).
This critique supports the notion that patients recently hospitalized for HF and other patients at
high risk for HF decompensation should be considered for comprehensive HF DM and/or
structured HF interventions including telephone support (Inglis et al., 2010; Gohler et al., 2006;
Roccaforte et al., 2005). Lindenfeld and colleagues (2010) describe high risk patients as those
with renal insufficiency, low output states, diabetes, chronic obstructive pulmonary disease,
persistent New York Heart Association (NYHA) class III or IV symptoms (Stage C or D HF),
frequent hospitalization for any cause, multiple active co-morbidities, or a history of depression,
cognitive impairment, inadequate social support, poor health literacy, or persistent nonadherence
to therapeutic regimens.
Based on the evidence documented, recommendations are provided by this author which
may aid in reducing re-hospitalizations and mortality in HF patients (Table I). However, it must
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be recognized that the evidence supporting recommendations is based on various population
responses that may not always apply to every individual or specifically for this pilot program.
Additionally, national guidelines can best serve as evidence-based recommendations for
management, not as mandates for every patient (Lindenfeld et al., 2010).
Table I. Key Elements of a Heart Failure Disease Management Program
Functional Capacity/Activity Level
Key Elements:
Evaluation and recording of functional
capacity/activity level and severity of
clinical disease based on the NYHA
functional classification for all HF pts.
during every admission or follow-up
visit (Lindenfeld et al., 2010).
• Evaluation and recording on
development and progression of the
disease: Stages A-D (Hunt et al., 2009).
Key Elements:
•

Development and progression of the disease

Disease Management

•

•

•
•

•

•
•

In-hospital phase of care built into the
DMP with care focused on optimizing
the patients’ clinical status, self-care
supportive strategies, medication
regimens, and on developing a postdischarge plan to address the
individualized risk factors of poor
discharge outcomes (Yu et al., 2006).
Comprehensive education and
counseling with patients and families
prior to discharge from an acute care
setting (Yu et al., 2006).
Consider screening for depression prior
to discharge (Riegel et al., 2006).
No delay in post-discharge appointment
with their PCP or clinic visit scheduled
within 7-10 days post discharge
(Phillips et al., 2005).
Continuation of post-discharge HF
education during clinic follow-up (Hunt
et al., 2009)
Consider structured telephone
interventions (Inglis et al., 2010).
Consider telephone interventions for
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Key Performance Indicators

medication counseling and review by
an APN with prescriptive authority
(Delgado-Passler & McCaffrey, 2006).
• Consider a multidisciplinary care team
as an effective structure in managing
HF patients on an inpatient and
outpatient basis (Lindenfeld et al.,
2010; Hunt et al., 2009; Gohler et al.,
2006).
Key Elements:
•

Cost / Benefit Monitoring
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Consider outcome measures of a DMP
focusing on readmission rates and
mortality (Taylor et al., 2009).

Key Elements:
•

Conduct cost/benefit analysis in order
to determine business case for inpatient and out-patient HF program(s)
(Hines et al., 2010; Inglis et al., 2010).

To ensure high-quality and efficient care for HF patients, the consistent use of clinical
practice guidelines developed by the American College of Cardiology (ACC), American Heart
Association (AHA), and the Heart Failure Society of America (HFSA) should be promoted
during and after hospitalization (Hunt et al., 2009; Lindenfeld et al., 2010). The HFSA guideline
incorporates elements and components for a HF DMP (Lindenfeld et al., 2010). The
recommended components include: comprehensive education and counseling individualized to
patient needs; promotion of self care, including self-adjustment of diuretic therapy in appropriate
patients (or with family member/caregiver assistance); emphasis on behavioral strategies to
increase adherence; vigilant follow-up after hospital discharge or after periods of instability;
optimization of medical therapy; increased access to providers; early attention to signs and
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symptoms of fluid overload; and assistance with social and financial concerns (Lindenfeld et al.,
2010).
In addition, a four-step process has been outlined by Hines and colleagues (2010) as a
guideline for evaluating an organization’s current processes and developing new approaches to
better manage the care of HF patients. Strategies for reducing HF readmissions require
significant analysis, planning, preparation, and appropriate execution in order to achieve positive
outcomes (Hines et al., 2010; Yu et al., 2006). According to Hines and fellow researchers (2010)
new payment models are currently being proposed within the US healthcare system which
creates a more compelling business case to manage post-acute care more effectively. Given the
significant volume of HF readmissions, as well as numerous potential policy changes focused on
reducing costs, HF patients may benefit from hospital initiatives focusing on readmission
reduction which is a key feature of the STAAR program.
The STAAR program provides acute care centers in Massachusetts an opportunity to
create an ideal transition home for HF patients. This initiative is supported by the
Commonwealth Fund with additional involvement and support from several organizations
including: Institute for Healthcare Improvement (IHI), Massachusetts Hospital Association
(MHA), Centers for Medicare and Medicaid Services (CMS), and Mass. Coalition for the
Prevention of Medical Errors (Massachusetts Hospital Association, 2009). Project leaders have
signed on 20 hospitals to pilot the STAAR Initiative’s “Transitions Home Collaborative” with
participating facilities located throughout the Commonwealth (Massachusetts Hospital
Association, 2009). The STAAR program provides acute care centers with an opportunity to
reduce re-hospitalization rates by 30% with implementing various strategies which may result in
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an increase of patient and family satisfaction with coordination and transitions in care
(Massachusetts Hospital Association, 2009).
Theoretical Basis for Change in Practice: Awareness-to-Adherence Model
Clinical practice guidelines have been created for HF and disseminated by numerous
authorities in the hope that clinicians will follow professionally advised prescriptions for best
clinical practice; however, clinicians do not always follow the practices recommended. The
Awareness-to-Adherence Model was proposed by Pathman, Konrad, Freed, Freeman, and Koch
(1996) is a framework for physician compliance which can be expanded and applied to
additional providers such as nursing.
Pathman and colleagues (1996) proposed that when clinicians comply with practice
guidelines, they must first become aware of the guideline, then intellectually agree with them,
then decide to adopt them in the care they provide, and then regularly adhere to them at
appropriate times. This model may prove useful in identifying ways to improve physicians’
and/or clinicians adherence to a variety of guidelines by demonstrating where they fall off the
path to adherence. Additionally, which are at greatest risk for not attaining each step in the path
and factors associated with a greater likelihood of attaining each step toward guideline
adherence. A number of potentially important explanatory variables which did not appear in
their analyses include physician and/or clinician use of performance feedback and use of prompts
placed on charts by office staff to alert clinicians to guideline needs.
The Heart Failure Society of America (HFSA) guideline incorporates elements and
components for a HF DMP which includes strong evidence (Lindenfeld et al., 2010). The
Awareness-to-Adherence Model applied the HFSA guideline as a key reference source for the
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program. The HF pilot used this model to increase practitioner use of the guideline
recommendations with HF patients during the acute care hospitalization and discharge process.
Protocol and Program Tailoring for HF Pilot Program
Project Design. An evaluation design was chosen for the Capstone Project. The HF
Pilot Program (HFPP) was designed to evaluate the efficacy and impact of a multi-disciplinary,
nurse managed Heart Failure Disease Management Program for patients admitted to the hospital
for HF that was modified specifically for the Critical Access Hospital. The design included pretest and post-test methods for the one group of patients seen during the HF Pilot Program which
will be referred to throughout this paper as “HFPP” from this place forward.
Sample. Sample inclusion criteria limited sample selection to those patients admitted for
HF who could be discharged home and then seen in the outpatient cardiology department for
their follow-up appointment 7-10 days post discharge. Prior to starting this pilot, it was
determined that patients who would be discharged to an extended care facility or to another acute
care facility will be excluded due to likelihood of loss to follow-up.
Program Facilitator/Capstone Project Director. The Critical Access Hospital (CAH)
HF Pilot Program (HFPP) Facilitator and Director of the Capstone Project is a University of
Massachusetts, Amherst, School of Nursing, Doctor of Nursing Practice candidate (DNPc) and
Family Nurse Practitioner candidate (FNPc) student who is affiliated with this CAH and author
of this project.
Institutional Review Board (IRB) Approval / Exemption. The HFPP Capstone Project
was designed as an evaluation project which was presented to the Critical Access Hospital health
system IRB and approved on December 22, 2010. All patient information was protected
according to hospital IRB policies as well as policies surrounding Health Insurance Portability
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and Accountability Act (HIPPA) (U.S. Department of Health & Human Services [HHS], n.d.).
Protection of data collection forms was maintained under double lock within the hospital and
will be destroyed at the earliest opportunity unless these data collection forms are found to be
pertinent for medical record justification.
Discussion of Outcome Measures to be used in HF Pilot Program
The HFPP outcomes for patients included patient satisfaction, readmission, mortality, and
functional capacity of the HF patients.
Patient Satisfaction. A patient satisfaction survey was developed by the program
facilitator and program assistant with submission of an amendment to the IRB for approval to
administer with HFPP patients; acceptance received on January 3, 2011 (Figure 8). All HF
nurses were informed that this survey would be provided to all HF patients during their
outpatient cardiology appointment as well as for those patients who may be lost to follow-up.
These surveys were completed anonymously with no patient identifier being listed on the form.
For those that were lost to follow-up, the survey was mailed to them asking to complete two
sections: Inpatient and Overall, and asked to return via an enclosed postage paid envelope.
Readmission. The population impact variables for the patients were re-hospitalization
rate and measurement of functional capacity. Re-hospitalization rates are currently measured
and reported by the CAH based on 30 day all-cause readmission rate (Figure 3). Mortality will
be discussed later in this paper under the Results, Data Analysis, and Interpretation section.
Functional Capacity. Functional capacity was obtained by a self-administered
questionnaire known as The Duke Activity Status Index [DASI] (Hlatky, Boineau,
Higginbotham, & Lee, Mark, Califf et al., 1989) (Figure 6). The DASI was administered to
each participant during their inpatient hospitalization period and after discharge during their
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outpatient appointment within the Cardiology Department. Additionally, it was determined that
if a particular patient was being discharged to home and would be unable to follow-up in the
outpatient program, the DASI would be administered 7-10 days post-discharge by the program
assistant or the program facilitator via telephone contact. This protocol change was approved by
the Critical Access Hospital IRB.
The DASI is a 12-item scale that assesses whether patients can perform a spectrum of
activities without difficulty and provides insights into selected aspects of their perceived quality
of life (Jaeger, Hlatky, Paul, & Gortner, 1994). Therapeutic efficacy is usually assessed in
clinical cardiovascular studies by measuring endpoints such as mortality or myocardial
infarction; yet these “hard” endpoints do not provide a picture of the effect of medical care on
the patient (Hlatky et al., 1989). A reliable and valid measure of ongoing patient outcomes in
terms of patient functional status would assess more subtle effects of therapy, and provide
patients and clinicians with information relevant for therapeutic decision-making. In addition,
the DASI measures functional capacity in metabolic equivalents (METS) which is a useful and
convenient way to describe the intensity of a variety of physical activities (Thompson, Gordon,
& Pescatello, 2010).
Defining physical activity, exercise, and physical fitness has been accomplished using
several methods, including percentages of maximal oxygen consumption (VO2max), oxygen
consumption reserve (VO2R), heart rate reserve (HRR), maximal heart rate (HRmax), or
metabolic equivalents (METs) (Thompson et al., 2010). Using METs allows values to be
obtained for each intensity category provided across a range of functional capacities (Armstrong,
Balady, Berry, Davis, Davy, & Davy et al., 2009). One MET represents an individual’s energy
expenditure while sitting quietly (Haskell, Lee, Pate, Powell, Blair, et al., 2007). Further
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defined, 1 MET = 3.5 mL-kg-1 –min-1 (Armstrong et al., 2009). Light physical activity is
defined as requiring <3 METs, moderate activities 3-6 METs, and vigorous activities >6 METs
(Thompson et al., 2010). Since the DASI uses the patient’s ability to perform a set of common
activities of daily living to gauge functional capacity based on the known metabolic cost of each
activity in MET units, it is thought to be well suited for population studies in which assessment
of functional capacity during follow-up is needed (Ainsworth, Haskell, Leon, Jacobs, & Montoye
et al., 1992; Hlatky et al., 1989).
Furthermore, individualized modifications in treatment plans can be made based on a
patient individual DASI scores comparing pre and post testing measures during their outpatient
cardiology appointments. From a physiologic function capacity standpoint, this data can provide
clinicians an indication of whether or not the patient is improving physiologically enough to
endure activities of daily living (ADL). Without this data, the clinician will not know if a patient
can perform certain ADL’s. Results from the Women’s Ischemia Syndrome Evaluation (WISE)
Study demonstrated usefullness of the DASI before exercise testing can risk stratify symptomatic
patients and may improve identification of higher-risk, functionally impaired subjects that would
benefit from pharmacologic stress imaging and targeted risk management (Shaw et al., 2006).
Program Goals for Specific outcome indictors. According to Issel (2004) goals are
broad, encompassing statements about the outcome to be achieved, whereas objectives are
specific statements about impacts to be achieved and are stated in measurable terms.
The goals for this program were:
Goal I: All inpatient HF patients will benefit by the Critical Access Hospital HFPP.
Goal II: HF patients who are discharged home will have individualized discharge follow-up in

the outpatient cardiology department at the Critical Access hospital.
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Goal III: HF patients who are seen in the outpatient cardiology department will have
individualized care.
Goal IV: The overall pilot program and population effectiveness will be continually monitored.
The program team identified specific objectives for each program goal, with clear
outcome measures for each of the objectives. The program objectives, outcome measures and
results are presented in Tables II-V. Examples of Expected Outcome Results listed in the
following Tables are discussed in detail in the Evaluation Section.
Table II – Inpatient HF Pilot Program
Goal: All Inpatient HF patients will benefit by the Critical Access Hospital HF Pilot
Program
Objectives
Outcome Measures
Results
Program Objective: All
Program Outcome: HF patients Outcome Score = 100%
identified HF patients will have will have a designated HF nurse While all pilot patients
a designated HF nurse caring for caring for them while inpatient
had a HF nurse caring for
them while inpatient at the
them during their inpatient
90% of the time.
CAH.
stay (100%), mishaps
occurred on the
medical/surgical unit
(2MS) on various day,
evening, and night shifts
with no designated HF
nurse caring for the
patient. The med-surgical
floor required frequent
oversight due to repeat
patterns of missed
opportunities with
protocol follow-through.
Several of these missed
opportunities pointed to no
HF nurse working on a
particular shift (scheduling
issue) as well as HF nurses
working yet not assigned
to a HF pilot patient (see
project limitations).
Program Objective: An
Program Outcome: HF patients Outcome Score = 100%
enhanced admission assessment will have an enhanced admission All HF pilot patients had
will include identification of
assessment identifying
the caregiver identified
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predicting post-hospital needs.
Population Objective: HF
patients and their designated
caregivers will be provided with
specific HF management
instructions utilizing “teach
back” techniques and “Ask me
3” techniques specifically for
provider teaching
(National Patient Safety
Foundation, n.d.)

caregivers for D/C planning and
predicting post-hospital needs
90% of the time.
Population Outcome: The
patient and/or caregiver will
verbalize understanding of HF
disease management as
demonstrated by “teaching
back” the instructions to the HF
nurse 90% of the time.

Program Objective: Identified
“new” HF patients will have a
cardiology consult while
inpatient. This goal will allow
“new” patients to be seen by the
Cardiology NP and program
facilitator on an outpatient basis.
(“New” HF patients are defined
as patients who have not been
seen by the cardiology
department at the CAH in the
past).

Program Outcome: A
cardiology consult will be
ordered by the hospitalist for
“new” HF patients who will be
discharged home 90% of the
time.

Program and Population Dual
Objective: The DASI
questionnaire will be provided
to HF patients during inpatient
status by the designated HF
Nurse. Inclusion criteria for the
DASI are those patients who
will be discharged home.
Program and Population Dual
Objective:
HF patients will have

Program and Population Dual
Outcome: HF patients who
meet the inclusion criteria will
receive and complete the DASI
questionnaire 90% of the time
during their inpatient stay.

Program and Population Dual
Outcome:
The “HF Discharge Time Out”
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during their inpatient stay.

Outcome Score = 88%
Two HF patients and/or
their caregivers were
unable to verbalize
understanding of HF
disease management based
upon the topic being
taught. While the “teach
back” method was utilized
with all HF patients and/or
their caregivers during
their inpatient stay,
opportunities in
documentation were noted
by the program facilitator
(addressed within the
evaluation section of this
manuscript).
Outcome Score = 100%
All HF pilot patients had a
cardiology consult while
inpatient. Out of the 17
patients who participated
in the inpatient program,
five patients were
established patients within
the cardiology department.
The remaining patients
were new patients or
patients who were not
seen for several years and
considered new patients.
Outcome Score = 100%
All identified HF pilot
patients who meet the
inclusion criteria
completed the DASI
questionnaire during their
inpatient stay.
Outcome Score = 82%
While the Discharge Time
Out document was utilized
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“Discharge Time Out” to be
completed by the discharging
HF nurse.

medical record form will be
completed on HF patients 90%
of the time.
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on all HF pilot patients,
there were three patients
in which the form was not
fully completed.

Table III – Transitions in Care
Goal: HF patients who are discharged home will have individualized discharge follow-up
in the outpatient cardiology department at the Critical Access Hospital
Objectives
Outcome Measures
Results
Program and Population Dual Program and Population Dual Outcome Score = 65%
Six patients were lost to
Objective:
Outcome:
Prior to inpatient discharge, an
HF patients will have an
follow-up and not seen in
appointment and referral will be outpatient cardiology
the outpatient cardiology
made to the outpatient
appointment within 7-10 days
department. Patients lost
cardiology department located
post discharge and be seen by
to follow-up are addressed
at the CAH for HF patients to be the Cardiology NP, 90% of the
further within the
seen 7-10 days post discharge.
time.
evaluation section of this
manuscript.
Program and Population Dual Program and Population Dual Outcome Score = 88%
Follow-up phone calls
Objective:
Outcome:
HF patients will have a followHF patients will accept a
were made to 15 patients
up phone call within 24-48
follow-up phone call within 24- post discharged: One
hours post discharge.
48 hours post discharge
patient died while inpatient
conducted by the program
with the second patient
facilitator or the program
being discharged on a
assistant 90% of the time.
Friday returning for
readmission on the
following Monday
requiring end of life care
and hospice involvement.
Minus the above two
patients, this outcome
score may be viewed as
100% with two outliers.
Table IV – Outpatient HF Pilot Program: To assess program effectiveness and impact on
target population.
Goal: HF patients who are seen in the outpatient cardiology department will have
individualized care.
Objectives
Outcome Measures
Results
Population Objective: HF
Population Outcome: HF
Outcome Score = 91%
patients will be seen within 7-10 patients will appear for their
Only one patient has
days post discharge by the
post-discharge out-patient
rescheduled and will be
Cardiology NP and program
appointment at CAH 90% of the seen the end of April.
facilitator.
time.
If NP is unavailable; pt’s will be
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Cardiologist if needed.
Population Objective: HF
patients who were discharged
from in-patient hospitalization
and who do not show for their
post-discharge appointment will
be contacted by phone with
specific follow-up questions and
opportunities to reschedule their
appointment. To be conducted
by the Cardiology NP and/or
Program Facilitator
Program Objective: The DASI
questionnaire will be provided to
HF patients who were
discharged from inpatient status
at the CAH during their
outpatient appointment.
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Population Outcome: HF
patient who are not seen for their
scheduled post-discharge
appointment will respond to the
call and set another appointment
90% of the time.

Outcome Score = 100%
No show rate was 0%
Only one patient has
rescheduled their
outpatient appointment.

Program Outcome: DASI
questionnaire will be completed
by HF patients (who were
recently discharged form
inpatient status) during their
outpatient appointment 90% of
the time.

Outcome Score = 76%
We were unable to obtain
post-discharge DASI on
four patients: three deaths
and one patient did not
return our phone followup call. Out of 17
patients who completed
the inpatient program, we
were able to obtain 13
post discharge DASI’s via
combination of follow-up
appointment and followup phone call.
Outcome Score =
See “Interpretation of
DASI scores” under
Evaluation section of this
manuscript.
Wilcoxson Signed Rank
Test demonstrated no
statistical difference
between inpatient and
outpatient oxygen (O2)
uptake; z = -.839a
Outcome Score = 100%
The cardiology NP
documented all
individualized plans
within each HF patients
EMR
Outcome Score =100%
All HF pilot patients

Population Objective: Based
upon the inpatient and outpatient
interventions, HF patients METs
score as calculated from answers
on the DASI will demonstrate
improvements.

Population Outcome:
Improvements of the METs
score as calculated from answers
on the DASI will be reported by
HF patients 90% of the time.

Program Objective: HF patients
will receive an individualized
treatment plan provided by the
cardiology NP.

Program Outcome:
Documentation regarding the
individualized plan is completed
for all HF patients 90% of the
time.

Program Objective: HF patients Program Outcome:
will receive additional teaching
Documentation regarding

TRANSITIONS HOME FOR PATIENTS WITH HEART FAILURE
provided by the Cardiology NP
and program facilitator
Population Objective: HF
patients and their designated
caregivers will be provided with
specific HF management
instructions utilizing “teach
back” techniques and “Ask me
3” techniques specifically for
provider teaching
(National Patient Safety
Foundation, n.d.)

education will be completed for
all outpatient HF patients 90% of
the time.
Population Outcome: The
patient and/or caregiver will
verbalize understanding of HF
disease management as
demonstrated by “teaching back”
the instructions the NP and the
program facilitator.
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received continued
education by the NP and
program facilitator.
Outcome Score = 100%
All HF pilot patients were
able to teach back key
components specific to
HF management while
home: weight monitoring,
decreased sodium intake,
and when to call NP with
worsening symptoms.

Table V –Evaluation of HF Pilot Program (Overall)
Goal: The overall pilot program and population effectiveness will be continually
monitored.
Objectives
Outcome Measures
Results
Program and Population Dual
Program and Population Dual Outcome Score = 65%
Eleven patients completed
Objective:
Outcome:
Patient who meet the inclusion
Patient who meet the inclusion
the entire program.
criteria for the HF Pilot Program criteria for the HF Pilot
Six patients were lost to
(identified while inpatient and
Program (identified while
follow-up in the outpatient
discharged home) will be
inpatient and discharged home) cardiology department.
included in the pilot both
will participate in the program
inpatient and outpatient.
to completion, 90% of the time.
Program and Population Dual
Program and Population Dual Outcome Score = 86%
Twelve surveys were
Objective:
Outcome:
Patients who have participated in Patients who have participated
completed and returned
the pilot program will be offered in the pilot program will
out of 14 patients (3
a satisfaction survey during their complete a satisfaction survey
expired). Patients were
outpatient visit.
90% of the time.
provided satisfaction
survey’s during their
outpatient appointments.
Patient who were lost to
follow-up were mailed a
satisfaction survey with a
stamped self addressed
envelope to return back to
the NP at the CAH (Tables
XI-XIII).
Program Outcome: Ninety
Program Objective:
Outcome Score = Unable
Dissemination of HF Pilot
percent of Stakeholders will
to determine.
Program findings will be
verbalize satisfaction of the
Dissemination of Findings
presented to all stakeholders in
pilot program results
scheduled at the CAH on
this proposal
Apr 28. “Verbalizing”
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Program Objective: The
program facilitator will evaluate
the program throughout Phase I.
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satisfaction is not an
appropriate measure;
rather data regarding
stakeholder satisfaction
should be obtained by an
anonymous survey similar
to what was used with HF
pilot patient satisfaction
surveys.
Program Outcome: The
Outcome Score = 100%
program facilitator will be
The program facilitator
successful in evaluating this
was successful in
program via data collection
evaluating this program as
during the entire Phase I process noted within the
90% of the time.
manuscript.

Specific Resource Program Outcome Indicators.
While the type and amount of resources required for a health program vary with the
interventions to be used, the expertise of the personnel, characteristics of the target audience, and
degree of attention paid to acquiring and managing resources all affect the success of a program
(Issel, 2004). Organizational inputs proposed for this HF Pilot Program include: Human
resources, informational resources, monetary resources, physical resources, managerial
resources, and time resources (Appendix B). The organizational plan objectives serve as a guide
as to which activities are the most critical for implementing a health program.
Service utilization inputs proposed for this HFPP include: Recipients, participants,
queuing, social marketing, and interventions (Appendix C). Before the HFPP can be delivered,
people need to know about it; this is the purpose of social marketing (Issel, 2004). Determining
through the process of screening based on criteria, who will participate in the program is another
aspect of the service utilization plan. The intervention delivery takes the most effort, yet can be
easily achieved if the planning has been well-developed. Prior to full program implementation, it
is best to pretest the program or “pilot” the program in order to analyze process components.
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Cost / Benefit Analysis of the HF Pilot Program
As noted in Figures 1, 2, and 3, opportunities for improvement at this CAH regarding HF
care were clear; yet building a clinical case for HF programs requires cost monitoring and
revenue analysis. These are important in demonstrating the business case for HFDM programs
and/or specific interventions (Hines, Yu & Randall, 2010; Inglis et al., 2010). Estimated costs
prior to implementation of this HF pilot program at this CAH are listed within the Proposed
Inputs and Outputs to the Organizational HF Pilot Proposal (Appendix A) and the Proposed
Inputs and Outputs to the Service Utilization Plan (Appendix B).
Chan and fellow researchers (2008) determined various cost estimates for HF disease
management programs which were standardized to 2005 US dollars by the consumer price index
for health care (Figure 10). In reviewing available data at this CAH for readmissions of HF
patients within 30 days during fiscal year 2009 - 2010, it can be estimated that the total charges
equaled $561,107.68 for 58 total readmissions with charges per case estimated to be $9,674.27
(personal communication, T. Rinaldi, November 21, 2010). However, understanding CAH
designation is another aspect to consider when calculating a cost-benefit analysis. Legislation
enacted as part of the Balanced Budget Act (BBA) of 1997 authorized states to establish State
Medicare Rural Hospital Flexibility Programs (Flex Program), under which certain facilities
participating in Medicare can become CAH (Centers for Medicare & Medicaid Services [CMS],
2008). Medicare pays CAHs based on reported costs; each CAH receives 101 percent of its
costs for outpatient, inpatient, laboratory and therapy services, as well as post-acute care in the
hospital’s swing beds (Medpac, 2007). CAHs are not subject to the Inpatient Prospective
Payment Systems (IPPS) and Hospital Outpatient Prospective Payment System (OPPS);
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Medicare pays CAHs for most inpatient and outpatient services to Medicare beneficiaries on the
basis of reasonable cost (CMS, 2008).
Additionally, benefits to the hospital in preventing readmissions are hard to calculate for
many reasons. For example, Centers for Medicare and Medicaid (CMS), Joint Commission (JC),
and Blue Cross and Blue Shield (BCBS) provide incentive payments to CAH’s for all HF
patients meeting specific HF core measure outcomes which are estimated to be approximately
3.75% per admission (G. Ritter, personal communication, November 18, 2010). However, the
amount of these payments is not public information. Therefore, a cost / benefit analysis for this
CAH is an estimate due to the inability to clear figures on these monetary benefits.
Finally, an important aspect to consider regarding cost-benefit involves doing what is
right for patients. For example, improvements in care may translate into avoidance of
readmissions which ultimately impacts quality of life (QOL) for these patients. Avoiding rehospitalization allows HF patients to live independently with their families and loved ones.
Thus, monetary benefits regarding QOL are also difficult to calculate. According to the United
States National Library of Medicine and National Institutes of Health (n.d.) it is rarely possible
or necessary to identify and quantify all costs and all benefits (or outcomes), and the units used
to quantify these may differ. It may be more appropriate to conduct a cost-effective analysis
(CEA) which is a comparison of costs in monetary units with outcomes in quantitative nonmonetary units, e.g., reduced mortality or morbidity. However, crossing the imaginary line into
rejection due to increased cost may not be the right approach (Figure 11). The tradeoffs of costs
and effectiveness require careful weighing with consideration to standards of care.
Inpatient Heart Failure Pilot Program. Attempts were made at the CAH in estimating
cost / benefit of the inpatient heart failure pilot program and listed in Tables VI – VIII
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Table VI. – Estimated Costs for Inpatient HF Pilot Program
Implemented for
Cost per Patient
Cost for Pilot
Pilot
N = 17 pts
Average hourly
nursing rate of
$31.25
Total cost for
1. DASI: 5-8
1. $5.21
inpatient pilot based
min.
on 17 patients
2. Education
2. $62.5
based on HF
book: total 2
3. $10.42
hrs.
Total: $ 1,328
3. DC time out: 2.5 hrs per patient
20 min.
Total: $ 78.13
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Annualized cost
N = 56 pts

Annualized cost for
inpatient program
based on 56 patients

Total: $ 61,264
(this is the cost of
nurses which is built
into their wages)

Table VI estimates what nurses are doing for the HF pilot patient at the CAH. They are
supporting the patient through the DASI, HF education book, and DC time out so that all
components are completed. For the nurse to accomplish and support this HF inpatient program
during hospitalization equals 2.5 hrs per patient = $78.13 x 17 pt’s = $1,328; to annualize =
$61,264.
Table VII demonstrates a breakdown on the readmissions during the pilot period.
However, a detailed discussion regarding readmissions is described within the results section of
this paper. Readmissions were reviewed to determine if the readmit was related to a HF
diagnosis. While hospitals report HF readmission as 30-day all cause, readmissions for this pilot
program revealed only one being related to a HF diagnosis with certainty; thus, 5.88%
readmission rate was determined for the first quarter of this HFPP.
Table VII – Breakdown on Reasons for Readmission within 30 days
Patient Number
Reason
LOS for
Related to HF
N=5
readmission
diagnosis?
105
Dyspnea / overlying 3 days
Questionable
pleural effusion
108
Coreg 25 mg b.i.d.
1 day
yes
not tolerated
110
End of Life
3 days
Questionable
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requiring hospice
112
Panic attack leading 1 day
Not directly
to SOB
115
Dyspnea /
9 days
Not directly
pneumonia
One patient out of 17 was readmitted due to heart failure diagnosis = 5.88% readmit rate
For 1st Q 2011
ANNUALIZED: 4 pt. in 2010 / 56 pts

= 7.14% readmit rate

To annualize, refers to expressing a variable in yearly terms even though the variable
does not directly apply to a year (Farlex Financial Dictionary, 2009). That is, an annualized
variable has been mathematically converted to yearly terms (Farlex Financial Dictionary, 2009).
An annualized variable is often theoretical; there is no guarantee that the rate in the example
above will be 7.14 % if it is calculated after a month or two.
According to Ross and colleagues (2010) there has been no recent national or regional
improvement in hospital readmission care among Medicare beneficiaries discharged after HF
hospitalization. Recent national hospital-specific risk-standardized readmission rates approached
25% for the most common discharge diagnosis among Medicare beneficiaries and the
distribution in hospital performance has not shown beneficial changes.
Table VIII – Benefit for Inpatient HF Pilot Program
Charges/case
2010
Readmission per pt
$9,766.16 loss
$68,596.96
Assume Contract
Reductions

= 40% of charges
received

23,438.78

2011 Annualized
$39,064.64
15,625.86
7, 812.92
Loss / cost
avoidance by
decreasing
readmissions

A main benefit for this CAH and other hospitals resides in cost / loss avoidance. Table
VII reflects the DRG charge per patient which is not reflective of cost. For every readmission,
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the CAH will not be paid yet care will still be delivered. Cost / loss avoidance is a benefit for all
hospitals when they can successfully decrease hospital readmission rates.
As previously stated, pay-for-performance models demonstrate financial incentives and
public recognition for top-performing hospitals as well as financial penalties for hospitals that do
not improve above a pre-defined quality measure thresholds (Premier, Inc., 2006). These figures
were not available from the CAH.
Outpatient HF Pilot Program. Attempts were made at the CAH to estimate the
cost/benefit of the outpatient heart failure pilot program and listed in Table IX.
Table IX. – Cost versus Benefit for Outpatient HF Pilot Program
Variables
Cost / Benefit
$72.63 per Medicare payment x 15 pt’s
$1,089.45 revenue for reimbursement
$ 0. per two patients due to health insurance $ 0 for reimbursement
With 17 patients x 30 min appt’s = 510 min =
8.5 hrs x 41.2 (average leadership salary range)
8.5 hr of NP time
= $350.2 cost

Increased revenue with Medicare was noted within the outpatient HFPP as noted in Table
IX. Reimbursement received based upon 15 Medicare patients versus the cost of an NP (with
average leadership salary range) demonstrates revenue of $739.25. However, annualizing cost or
reimbursement was not possible for the outpatient components of the program due to inability in
obtaining clear figures surrounding monetary benefits.
Finally, as a consequence of limited data regarding the cost-benefit of HF DMP’s in general,
several aspects of HF cost of care remain poorly understood especially in the area of HF resource
use in the outpatient setting (Liao et al., 2007). Accountable Care Organizations (ACOs) are
projected to become a new trend in health care with potential to create opportunities for rural
health care providers to improve health care quality and control health care costs within their
communities (MacKinney, Mueller, & McBride, 2010). MacKinney and colleagues describe
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these ACOs as payment and delivery system reforms to improve health care quality and control
costs through care coordination and provider collaboration, with accountability for its
performance.
The ACO model has received significant attention among policymakers and leaders in the
healthcare community in the context of the ongoing debate over health reform, not only because
of the unsustainable path on which the country now finds itself but also because it directly
focuses on what must be the key goal within our healthcare system: higher value (Lowell &
Bertko, 2010). This particular HF Pilot Model would fit into an ACO model of care in terms of
care coordination and provider collaboration.
Timeline of HF Pilot Program
Nov – Dec. 13, 2010; HF Pilot Proposal submitted with acceptance by doctoral
committee members and the designated mentor for the project at the CAH. Met
with key stakeholders throughout this period. Worked on developing necessary
tools for data collection.
Dec. 13, 2010 – December 31, 2010; all necessary aspects were in place:
Documentation tools, clinician roles, staff education, and IRB approval.
Contacted biostatistics department at UMASS, Amherst for statistical consulting.
IRB approval granted December 22, 2010.
Phase I: HF Pilot Program (HFPP) Implementation: Jan 1, 2011-March 31, 2011;
Inpatient & Outpatient HF program in place.
April – April 30, 2011; Analysis of results:
o Approx. 15 - 20 patients were initially estimated. Actual patients equaled
seventeen.
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April – May 01, 2011; written evaluation of program and dissemination of
findings to UMASS, Amherst and the CAH.
o Data analysis: Includes statistical analysis with assistance by a
biostatistician at UMASS, Amherst and comparative qualitative analysis
of findings by comparative review: case by case.
Phase II: Post Doctoral ~ Continuation of Program; CAH Senior Management
determined feasibility for continuation of HF program for an additional three
months, scheduled to end on June 30, 2011. Adoption of program will be
determined upon analysis of outcome measures.
HF Pilot Program Development and Implementation
In order to design an effective program for HF patients at the CAH, the program
facilitator conducted an assessment of the “current state” of HF treatment in the setting. Based
on this assessment, the program facilitator developed the HFPP based on the recommendations
from the Clinical Practice Guideline and best evidence.
Medication Reconciliation. According to various officials at the CAH, the new
electronic medication reconciliation process instituted during November 2010 was designed to
alleviate medication fall-outs. Medication reconciliation process at the CAH was projected to
reach 100% compliance due to their recent electronic advancements within the electronic
medical record and pharmacy division. This recent advancement was expected to be beneficial
during all patient admissions and during the discharge process. Mechanisms were in progress
outside of this pilot to track and monitor this process.
Despite these efforts, two medication issues occurred during the HFPP with discharge
medications, both regarding combivent (ipratropium bromide and albuterol sulfate) a known
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bronchodilator. These two problems impacted HF Core Measures. The Quality management
staff addressed these issues with various staff and council members at the CAH. Opportunities
for improvement in medication reconciliation exist including double checking/safety net
mechanisms with another staff member to ensure all key items are in place prior to discharging a
patient in order to avoid any additional medication discrepancies.
Multidisciplinary care team with specialized HF nurses. The evidence supports the use
of a multidisciplinary care team as an effective structure in managing HF patients on an inpatient
and outpatient basis (Lindenfeld et al., 2010; Hunt et al., 2009; Gohler et al., 2006). In addition,
an effective intervention to reduce hospitalizations encourages consistency of specially trained
nurses in providing acute care for patients with chronic conditions such as HF (Boutwell, Griffin,
Hwu, & Shannon, 2009). While the CAH incorporates a multidisciplinary approach to patient
care, they did not have designated specially trained HF nurses.
Evidence supports the effectiveness of a designated trained HF nurse who works with the
patient and family or caregiver during the hospitalization to conduct patient education, arrange
post-acute follow-up, confirm medication reconciliation, and prepare them for discharge
(Boutwell & Hwu, 2009). The program facilitator provided pilot education to all the HF
designated nurses to ensure they understood the pilot purpose along with various outcome
measures for evaluation.
Effective Teaching and Enhanced Learning. According to Joint Commission (JC)
(2010) HF patients or caregivers discharged home must be given written instructions or
educational material. These materials must address all of the following: activity level, diet,
discharge medications, follow-up appointment, weight monitoring, and what to do if symptoms
worsen. Prior to this pilot, the CAH provided HF patients and their families with an evidence-
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based HF education packet which describes simple pathophysiology of HF, along with dietary,
activity, weight monitoring, and symptom monitoring within the booklet entitled: “A Stronger
Pump: A guide for people with all types of Heart Failure” (Purcell & Fletcher, 2009). In
addition, the packet contains a stop light laminated sheet (8.5 x 11) describing signs and
symptoms and what to do if they are in a green, yellow, or red zone. This stop light is designed
to guide patients and families in monitoring their status and providing guidance instructions for
recommended follow-up. However, there was no system in place to track patient or caregiver
understanding of this packet.
Lindenfield and fellow researchers (2010) have described the importance of adequate
patient and family or caregiver teaching. They report that inadequate education and counseling
can lead to the following (p. e101):
•

Poor communication and coordination of care among health care providers.

•

Inadequate discharge planning.

•

Failure to organize adequate follow-up care.

•

Clinician failure to emphasize non-pharmacologic aspects of HF care, such as
dietary, activity, and symptom monitoring recommendations.

•

Failure to address the multiple and complex medical, behavioral, psychosocial,
environmental, and financial issues that complicate care, such as older age,
presence of multiple co-morbidities, lack of social support or social isolation,
failure of existing social support systems, functional or cognitive impairments,
poverty, presence of anxiety or depression.

•

Failure of clinicians to use evidence-based practice and follow published
guidelines in the prescription of pharmacologic and non-pharmacologic therapy.
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While the Critical Access Hospital provided an education packet to all HF patients, little
was known about the participation and engagement of patients and families or caregivers. This
evidence based educational packet includes comprehensive education strategies and counseling
for patients and families prior to discharge from an acute care setting (Yu et al., 2006; Boutwell,
Jencks et al., 2009). Effective teaching to enhance learning should include “teach back” daily in
the hospital to assess patients’ and family understanding of discharge care and ability to perform
them (Weiss, 2007; CAH, 2010 February). Since teach back was not utilized in this setting, the
program assistant designed a teach-back plan for the program. The teaching document entitled:
“Heart Failure Pilot Program – Patient Teaching “A Stronger Pump” was developed by the
program assistant to capture key aspects of HF understanding demonstrated by the patients and
their caregivers (Figure 7).
According to Weiss (2007) only about 13% of the American adult population have fully
developed health literacy skills and can read and understand virtually all text and numerical
information they might encounter in health care settings. Based on the increase in HF
readmission rates at this CAH, it is important to evaluate if patients understand their role in
managing HF (Yu et al., 2006). As part of this HFPP, the HF nurse’s assessed and documented
the patient and family understanding of their role in management of HF prior to discharging
them home.
Consistency with HF Teaching. In order to maintain consistency in terms of HF
teaching during hospitalization, key nurses were identified on the medical-surgical unit (2MS)
and in the critical care unit (CCU) for the day, evening, and night shifts and became known as
the “HF pilot nurses”. These nurses were trained by the program facilitator along with the
program assistant in discussing key aspects of HF care based on the HF Education Packet which
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is currently in use at this CAH (Purcell & Fletcher, 2009). In addition the selected HF pilot
nurses were instructed to watch a DVD entitled: “Teaching Moments: Educational In-Service”
by Reske and Rucki (Fairview Hospital [FVH], 2010). On February 3, 2010 this particular inservice was presented at the CAH which described various teaching methods in order to enhance
educational opportunities while caring for patients. The program facilitator viewed this DVD
prior to program development to determine if the contents were suitable for pilot
implementation. Various components were described in this DVD including but not limited to:
Ask Me 3 (National Patient Safety Foundation. n.d.).
A systematic approach was developed and created by the program assistant to aid these
HF nurses in teaching key factors for HF management (Figure 7). It is particularly important to
establish consistency between individuals when teaching patients about HF management or when
abstracting data from medical or other records (Issel, 2004). The teaching document allowed all
HF nurses to follow the educational aspect of this program closely with clear documentation on
what items were achieved, which in turn allowed the program facilitator to revisit these items
with HF patients during their scheduled outpatient cardiology appointment.
All HF patients received education by a designated HF pilot nurse to determine gaps in
knowledge. After delivery of patient education, the impact was assessed prior to discharge
utilizing the “teach-back” and “Ask me 3” methods (Fairview Hosptial, 2010, February; National
Patient Safety Foundation, n.d.). The patient and/or caregiver understanding were documented
by the HF nurse within the patients’ medical record. Opportunities in documentation were noted
by the program facilitator and addressed within the evaluation section of this manuscript.
Post-discharge during the follow-up phone call and outpatient appointment with a
cardiology trained Nurse Practitioner (NP); patient knowledge was reassessed utilizing the teach-
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back method. In order to maintain consistency, the same educational HF Packet was referred to
during follow-up phone calls, and during the outpatient appointment.
While all HFPP patients received designated HF pilot nurses during their inpatient stay,
there were several shifts on the medical-surgical unit (2MS) resulting in no HF nurse caring for a
HF pilot patient. On several occasions it was due to no HF nurse working the shift pointing to a
scheduling concern; while on other occasions it was discovered that a HF pilot nurse was
working the shift, but not assigned to the HFPP patient. Anecdotal conversations revealed that
additional education was warranted to the charge nurses on 2MS. Key managers were informed
in order to actualize process improvements with HF pilot identification and for proper protocol
adherence.
One charge nurse on 2MS recommended that all nurses be “HF nurses” in order to
minimize additional fall-outs. Given IRB requirements, any nurse who becomes a designated
HF nurse for this pilot must complete NIH certification and follow all IRB requirements.
Discharge Instructions. Previous outcome data on HF core measures at the CAH
demonstrated opportunities for improvement specifically with discharge instructions. The
analysis of HF discharge errors identified issues with discharge medications, weight monitoring,
and smoking cessation counseling (Figure 4).
The HF core measures reports presentation of the patient discharge instructions, yet there
were no current measures of the patient understanding of their discharge plan. Therefore, the HF
nurse was instructed to assess and document the patient and/or caregiver understanding of HF
disease management within their discharge note in the computerized electronic medical record
(EMR).
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Discharge “Time-Out”. Based on the problem identification, a discharge time-out
document was developed which was completed prior to discharge by the designated HF nurse
(Figure 5). This Discharge Time-Out document allowed all HF designated nurses to ensure all
key items have been addressed prior to discharging HF patients. The completed form was
collected post discharge by the program facilitator or program assistant and filed under double
locks.
Results of these forms demonstrated that various items were not consistently completed
by the discharging HF nurse. During the pilot, efforts were made to convey the importance of
each item being addressed. Additionally, it was communicated to the HF nurses that the
Discharge Time-Out document can be started upon admission in order to ensure all items are
addressed.
Follow-up appointment at time of discharge. Numerous studies and national guidelines
support the importance of follow-up appointments to a primary care practitioner or specialty
office at time of discharge; yet no formal process existed at this CAH (Delgado-Passler &
McCaffrey, 2006; Inglis et al., 2010; Lindenfeld et al., 2010). A recent study by Jencks,
Williams, and Coleman (2009) reviewed Medicare claims data from 2003-2004 to describe the
patterns of re-hospitalizations and characteristics of hospitals. In the case of 50.2% of the
patients who were re-hospitalized within 30 days after a medical discharge to the community,
there was no bill for a visit to a primary care or specialty physician’s office between the time of
discharge and re-hospitalization (Jencks et al., 2009). The current evidence on the post discharge
management of HF recommends that patients recently hospitalized for HF obtain a postdischarge appointment with their PCP or clinic visit scheduled within 7-10 days post discharge
(Lindenfeld et al., 2010; Phillips et al., 2005). This program included nursing follow up on the
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scheduling of this appointment and patient reminder prior to discharge for every HFPP patient.
They were documented on the Discharge Time-Out document (Figure 5).
Structured telephone follow-up. National guidelines and research support telephone
follow-up post discharge to HF patients (Delgado-Passler & McCaffrey, 2006; Inglis et al., 2010;
Lindenfeld et al., 2010). In addition, the evidence supports telephone interventions for
medication counseling and review by an APN with prescriptive authority (Delgado-Passler &
McCaffrey, 2006). While there has been much discussion and efforts made at the CAH to
conduct these telephone follow-up calls, it remains unclear how this intervention would be
systematic or how data would be utilized, tracked, or disseminated.
For the HF Pilot Program (HFPP), follow-up telephone contact was made by the program
facilitator (DNP student) or the program assistant within 24-48 hours post discharge utilizing the
“HF Routine Telephone Call” document (Figure 9). The completed form was collected after
telephone contact was established by the program facilitator or program assistant and filed under
double locks. This HFPP included availability of the cardiology NP for notification by the
program facilitator or program assistant if reported patient symptoms required specific advanced
nursing action.
Implementation Continued: Monitoring and Modification
Fidelity
Fidelity may be defined as the quality or state of being faithful: factual accuracy of
details and exactness (Merriam-Webster, 2011). Intervention fidelity refers to the consistency of
the program implementation, including all elements of the intervention. There were several tools
to ensure fidelity which include: DASI Questionnaire, HF Pilot Program (HFPP) Patient
Teaching “A Stronger Pump”, Discharge Time Out, Post Discharge Follow-Up Phone Call, and
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HF Pilot Program (HFPP) Patient Satisfaction. Patients were screened by the program assistant
beginning January 1, 2011 thru March 31, 2011 focusing on admission diagnosis related to
dyspnea/shortness of breath (SOB), pneumonia, chest pain, atrial fibrillation, and renal failure. In
addition, brain natriuretic peptide (BNP) test were also analyzed for potential rule-in/rule-out
diagnosis of HF. A screening log was maintained by the program assistant per recommendation
of the health system IRB. A total of 64 patients were screened for this pilot, from Jan 1- March
31, revealing seventeen total candidates.
Ensuring Educational Fidelity (consistency). Shortly after initiation of the HFPP, it was
discovered by the pilot program assistant that a teaching document was needed for all designated
HF nurses to use in order to gauge education efforts based on the CAH existing HF packet.
Thus, the data collection document was developed by the program assistant and submitted to the
IRB for approval with acceptance received on January 3, 2011 (Figure 7). All HF nurses were
informed of the need to document their strategies with educational efforts in alignment with the
education booklet entitled: “A Stronger Pump: A guide for people with all types of Heart
Failure” (Purcell & Fletcher, 2009). This document proved to be helpful for all the HF nurses
with determining how they should focus their educational strategies. This in turn proved to be
beneficial for all shifts in gauging where the gaps reside in terms of teaching the patient and their
caregiver on key aspects surrounding HF disease management. Items which were not covered or
required additional attention were addressed during their outpatient cardiology appointment by
the program facilitator. The program facilitator utilized the same teaching document during their
outpatient appointment to ensure concepts were understood by the patient and/or caregiver.
Functional status was measured by the DASI. This instrument was used for the preprogram measure (inpatient) and post program measure (outpatient). The post program DASI
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was measured at the post discharge NP visit. For those patients who would be lost to follow-up,
the program facilitator or the assistant completed the post program DASI by telephone with the
same instrument. The completed DASI questionnaires for this pilot were entered by the program
assistant or program facilitator into a BHS owned laptop utilizing an excel spreadsheet; secured
with double locks. Completed questionnaires were filed and maintained by the program
assistant within a secured double lock system. Upon pilot completion, data analysis was
accomplished on aggregate group results by a biostatistician at the University of Massachusetts
Amherst for interpretation utilizing appropriate statistical tests. Individual analysis of results
was not completed for this HF pilot project to protect anonymity of the data and patients’
confidentiality at this time.
Follow- up visit with Cardiology NP. The CAH has a full time cardiology NP who
agreed to see all HF pilot patients post discharge. An early pilot program change incorporated
the addition of another NP at the CAH affiliate in order to capture potential HF patients which
would ultimately allow the CAH to see the affiliate’s patient in the outpatient setting. Addition
of this NP to the project staff was submitted via an amendment to the IRB with approval
received on February 10, 2011. This new NP was educated by the program facilitator regarding
various inpatient pilot measures which were currently being captured at the CAH such as
administration of the DASI, patient education with the CAH booklet with documentation form,
and discharge time out. The NP agreed to notify the program facilitator with potential patients
which would then be followed by the CAH on an outpatient basis. Despite the addition of this
NP from the CAH affiliate, no new patients were captured for this particular pilot program.
Should this HFPP lead to adoption, collaborative agreements between both facilities deserve
attention.
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Research Training. The IRB notified the program facilitator in mid February, 2011,
regarding project staff for this pilot. It was noted that several of the designated HF nurses did
not achieve National Institute of Health (NIH) Certification regarding protection of human
subjects which is a requirement by the Critical Access Hospital IRB when incorporating these
HF nurses as project staff. It was determined that the remaining nurses who did not have their
NIH certification (13 nurses), must complete that process in order for the HF project to continue
along with submission of their signatures on the project staff IRB form. Thus, the program
facilitator worked with these 13 nurses and coached them on how to obtain NIH certification.
Within a three to four week period, all designated HF nurses were NIH certified along with
submission of their project staff forms to the Critical Access Hospital IRB. There were a total of
22 designated HF nurses for this pilot project. A sixth amendment form was filed with the IRB
regarding the project staff update listing all 22 HF nurses; amendment approval was received on
March 15, 2011.
Adaptability
This may be described as the ability to change or be changed in order to fit or work better
in some situation or for some purpose: or be adapted to change to fit changed circumstances
(Merriam-Webster, 2011). According to Melnyk and Fineout-Overholt (2005) it is essential to
have a written strategic plan with clearly described goals for a change in evidence-based practice
(EBP) to occur. Additionally, lack of a detailed plan is a major barrier to implementing a
change.
It was anticipated and observed with this HFPP that the identified HF nurses would vary
in their individual personality styles while implementing the HFPP which ranged from “drivers”,
“inspired”, “supportive and steady”, to “contemplators” (Melnyk & Fineout-Overholt, 2005).
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The program facilitator was responsible for this change effort by facilitating strategies to work
successfully with each of them. It was soon discovered that varying degrees of skepticism would
occur if the change is not clearly understood, if they are fearful about it, or if they have
misperceptions about why change is needed.
In order to ensure adaptability, the program facilitator and program assistant frequently
visited the inpatient units throughout this HFPP. Educating the HF nurses about this EBP change
was an ongoing endeavor from the beginning of this HFPP to the end. Prior to the start of this
HFPP, the program facilitator met with all HF nurses on the medical surgical floor and during a
staff meeting on the critical care unit (CCU) to discuss how this pilot would be rolled-out. A
“Heart Failure Pilot Program”(HFPP) note book was made by the program facilitator and
program assistant for use on each unit with detailed instructions regarding all necessarily
documents on how to capture the necessary HFPP data as well as the program facilitator and
program assistant contact information. All HF nurses were encouraged to contact them during
the pilot for any assistance or clarification. Electronic messages from the program facilitator
were also used in order to maintain communication efforts during this pilot. All HF nurses were
asked to provide any feedback, comments, or suggestions regarding pilot measures or potential
for improvements.
Anecdotal verbal responses from the HF nurses were obtained by the program facilitator
while visiting the inpatient units at the CAH. Comments derived from the medical-surgical unit
(2MS) pointed to the overabundance of paper work during the discharge process which may be
displaced and not necessarily due to this particular pilot. Other anecdotal verbal responses by
some of the HF nurses pointed to positive aspects of this pilot including how much they learned
along with their patients and caregivers with the enhanced teaching portion.
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Previously discussed in this paper, the Awareness-to-Adherence Model applied the Heart
Failure Society of America (HFSA) guideline as a key reference source for this HFPP
(Lindenfeld et al., 2010). This model was chosen in order to increase practitioner use of the
guideline recommendations with HF patients during the acute care hospitalization, and discharge
process. For ease of access, the Heart Failure Society of America (HFSA) guideline was printed,
placed in a binder, and made available on the 2MS unit for all project staff and clinicians as a
reference guide surrounding heart failure care.
The entire hospitalist group and cardiology group demonstrated positive support for this
HFPP. They informed the program facilitator when potential candidates were identified and
shared results of diagnostic studies.
Results, Data Analysis, and Interpretation
As more funding agencies require health programs to document their success, the
evaluation becomes more integral to the actual intervention and overall program delivery (Issel,
2004). The program facilitator monitored and recorded the baseline outcomes. These were
major components of the process evaluation.
Patient screening and tracking endeavors were conducted by the program assistant and
program facilitator which were entered into an excel spreadsheet as recommended by the Critical
Access Hospital IRB. The CAH Quality Management Department assisted the project with
developing an excel spreadsheet to track and monitor patient education outcomes and DASI
results.
Population Results
Out of 67 patients who were screened, there were a total of 17 participants who received the
inpatient HFPP (Table X).
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Table X. Number of HF pilot participants n = 17
Number of patients receiving inpatient pilot program to its entirety

17

Number of patients receiving outpatient pilot program to its entirety

11

Number of patients who were lost to follow-up

6

Number of patients who completed the inpatient & outpatient DASI

13

Number of patients receiving portions of the inpatient pilot program,
but were excluded prior to discharge

8

Number of HF pilot patients readmitted within 30 days (due to HF)

1

Number of patients seen for an emergency room visit post discharge
from HF Pilot program (treated and released)

2

Number of patients who expired requiring reporting to CAH IRB
(one inpatient; two outpatient)

3

Number of returned patient satisfaction survey’s

12

There were a total of 17 patients who received the inpatient portion of the HFPP during their
hospital stay. Six of those patients were lost to follow-up; three of the six expired (one inpatient
and two outpatient deaths); one patient resided in another state and had two readmissions during
the pilot program (patient number 105 and 112) with the first admission and subsequent two
readmissions lost to outpatient cardiology follow-up. Further analyses of these patients will
occur within the readmission and mortality discussion.
Eleven patients (65%) completed the entire HFPP (inpatient & outpatient) with continued
care in the outpatient cardiology department. During their outpatient appointment with the
cardiology NP and program facilitator, a physical assessment was obtained including weight,
blood pressure, and observing for any physical assessment signs of heart failure. In addition,
medications were reviewed and discussed along with adjustments being made by the NP if
warranted. Heart failure education was reviewed by the program facilitator utilizing the same
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approach as noted during their inpatient hospitalization at the CAH. Of the eleven patients seen
in the outpatient HFPP, one patient was sent to the emergency room for evaluation of tachycardia
with a HR of 140, and one patient required an outpatient chest x-ray due to notable dyspnea with
lung auscultation revealing course crackles; this patient refused emergency room evaluation.
This patient was ultimately readmitted several days later with worsening symptoms. Further
analyses of this particular patient will occur within the readmission discussion. Both of these
cases represent proactive symptom management that could have avoided emergency situations.
A total of eight patients received portions of the inpatient HFPP during the ruling-in / rulingout process primarily due to a questionable diagnosis of HF. As described in the heart failure
guideline, HF is a syndrome with notable co-morbidities such as pneumonia, renal failure, and
pulmonary congestion. It became apparent during the inpatient aspects that HF may not be
readily identified due to underlying co-existing conditions. Chest X-Ray was not always
definitive nor having an elevated BNP level. Thus, during the ruling-in/ruling-out process
several patients who were thought to have HF did not, and vice versa.
Follow-up Phone Calls. Fifteen patients received a telephone follow-up call 24-72 hours
post discharge. During this pilot, the cardiology NP was notified once regarding a patients
discharge medication. It was determined by this NP that no additional intervention was
warranted since the patient had enough medication and was scheduled to be seen in the
outpatient setting whereby all medications would be reviewed.
Patient Satisfaction. Patient Satisfaction was measured with a tool developed for this
program. The same survey was used for all patients in the program. A total of 12 satisfaction
surveys were obtained. Mean scores were calculated for each question utilizing an excel
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spreadsheet (Tables XI-XIII). Each item was based on a likert scale ranging from very poor = 1,
to very good = 5, which can be reviewed in figure 7 of this manuscript.
Table XI.
A. In-patient Education (Your hospital stay)
1. The education portion was effective in
teaching me new information and
reinforced information I already knew.
2. The nurses presented the education
material with enthusiasm.
3. The nurses were knowledgeable and
well prepared to present education material.
4. The education sessions covered all
necessary information and answered
my questions.

Average
Score
4.9

5
4.9
5

Comments:
Pt. #1: Per patients’ spouse: "Care at this hospital was excellent, however, they
didn't send his records down to FL and it was urgent at the time."
Pt. #6: "Beds lumpy & uncomfortable. Night & day nurses are great. Night
assistants too noisy".
Pt. #12 - "The nurses were very empathetic to my condition & very helpful in
teaching thoroughly my new conditions and needs"

Table XII.
B. Out-patient Education (In the Cardiology Dept.)
5. The education portion was effective in
teaching me new information and
reinforced information I already knew.
6. The nurse practitioner(s) presented the
education material with enthusiasm.
7. The nurse practitioner(s) were knowledgeable
and well prepared to present education
material.
8. The education sessions covered all
necessary information and answered my
questions.

Average
Score
4.7

4.8
4.9

4.8

Comments:
Pt. #7: "I was very pleased"
Pt. #11: "Unfortunately you do not offer preventative care program which makes
some of this info null & void"
Pt. #12 - "I'm very satisfied with the services provided to me"
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C. Facility and Nursing (Overall)
9. All staff provided an appropriate level
customer service.
10. The heart failure program
provided all the information I needed.
11. The facilities are clean and safe.
12. Please rate the overall care you received
during the program.
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Average
Score
4.9
4.8
4.9
4.9

Comments:
Pt. #4: "Very happy with all"
Pt. #12: "The doctors, nurses, and all help acted and provided my needs above the
appropriate standard of service"

Six surveys revealed brief comments. Handwritten comments have been shared with the HF
nurses and department managers. Anecdotal verbal responses obtained from patients during
their outpatient appointment included: “How much they learned about HF” and “I’ve never been
taught this much before”.
Readmission
The breakdown on reasons for readmission demonstrated five 30-day all-cause
readmissions (30%) during the pilot program period from Jan 1 – March 31, 2011 (Table VII).
However, according to Table VII, only one patient was readmitted specifically due to previous
HF care (5.88%). One particular patient deserves close attention given that this patient received
the inpatient program initially in January, but was readmitted in February (patient number 105),
and again in March (patient number 112). In addition, this patient was lost to cardiology
outpatient follow-up since the established cardiologist who was involved with the care of this
patient, resided out of state. Thus, this patient did not participate in the outpatient HF aspect of
this program. The HFPP facilitator identified a local primary care practitioner (PCP) for this
patient, after the patient was discharged in March.
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Attempts could have been made during previous admissions for this patient in
establishing a follow-up appointment with the local PCP in order to avoid any additional
readmissions. While this patient was told to follow-up with his PCP per documentation in the
medical record, no follow-up appointment was made on behalf of the HF nurse or the case
management team. Lost opportunities were realized after the second readmission by the program
facilitator in terms of ensuring this patient had a follow-up appointment with the designated PCP.
Care across State Lines. One patient was unable to complete the entire program because
they lived in a different state from the CAH. Efforts were made by the program facilitator to
determine how to best manage care with patients who reside out-of-state with both the hospitalist
group and the case management department. The quality management department in
conjunction with the case management department has developed a focus study regarding 30-day
readmissions. Key questions are being obtained from readmitted patients to aid the CAH in
recognizing opportunities for improvement. While the PCP listed for this particular patient
resides locally, there were no documented efforts made to contact this PCP in order to discuss or
establish timely follow-up care in order to avoid unnecessary readmissions.
Readmission for patient number 108 suggests it was due to inpatient heart failure
management with carvedilol (Coreg) 25mg bid being prescribed one day prior to discharge. The
patient had an adverse reaction once discharged home due a syncopal event with loss of
consciousness prompting emergency service notification. The patient was subsequently
readmitted with the carvedilol dose being decreased to 12.5 mg daily which was tolerated well.
Patient number 115 deserves attention as well given that the first initial presentation in
March resulted in a lengthy hospital admission of 11 days and 9 days for the subsequent
readmission period. Although the NYHA classification system is not utilized at the CAH, this
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patient would have likely been staged as class IV due to a reported ejection fraction of 20% with
symptoms of cardiac insufficiency present at rest (Lindenfeld et al., 2010). In addition to being a
bilateral amputee, multiple co-morbidities have been established with this patient pointing to the
rationale for the lengthy admissions. A follow-up phone call was attempted with this patient
after the initial admission yet the patient was not available nor was the phone call returned to the
program facilitator or assistant by this patient. Fortunately, the patient appeared for the
cardiology outpatient appointment with the NP and program facilitator less than 10 days post
discharge after the initial admission revealing significant sedation due to narcotic use, SOB,
diaphoresis, right basilar crackles with scattered wheezes and diminished left base. This patient
refused emergency room evaluation, but agreed to an outpatient chest x-ray and labs; results
were reviewed by the NP and cardiologist. Two days later, the patient appeared in the
emergency room with worsening SOB and admitted with a questionable diagnosis of HF versus
pneumonia. After another lengthy admission of 9 days, the patient was notified via follow-up
phone call by the program facilitator reportedly doing the same, denying any worsening
symptoms. The outpatient appointment in the cardiology department was made prior to
discharge, but this patient reportedly rescheduled for factors unknown. Histories of nonadherence to therapeutic interventions were noted with this particular patient.
Of particular interest with this patient (#115) points to the verbalization of dissatisfaction
in not being accepted for the cardiac-rehab program at this CAH. Criteria for acceptance into
cardiac-rehab do not include a diagnosis of HF. According to Stevens (2009) the Centers for
Medicare and Medicaid Services (CMS) recognizes myocardial infarction (MI), coronary artery
bypass grafting (CABG) surgery, stable angina pectoris, percutaneous coronary intervention
(PCI), heart valve repair or replacement, and heart transplantation as additional indications for
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formal cardiac rehabilitation. CMS declined to add HF as an indication. However, CMS
signaled that it is waiting for the results of a current U.S.-wide trial on HF and would reconsider
this indication in light of its results (McDermott Will & Emery, 2011). Despite these
explanations, patient #115 asked: “Do I need to get worse before I get better to qualify?”
Clearly, a question which prompts much thought on behalf of all clinicians especially in light of
the importance surrounding physical exercise.
Mortality
Three patients (17%) expired during the three month HFPP period. One patient expired
during inpatient hospitalization, and two expired post-discharge. Hospital mortality rates include
those patients who expire during their hospitalization; outpatient mortality is not accounted for.
Despite this, two patients who expired and listed in a local newspaper was noted by the program
facilitator and reported to the IRB. Thus, a mortality rate for inpatient deaths during this pilot
resulted in one patient (5.8%). It was determined that the inpatient death was not due to HF,
rather it was presumed to be a pulmonary embolism as the identified cause.
Functional Status: Interpretation of DASI scores
The DASI pre program and post program scores were entered into SPSS and the
distribution of scores demonstrated a normal distribution for both the inpatient and outpatient
oxygen (O2) uptake scores (Figures XI-XII). Thus, it can be assumed that the populations from
which the samples are taken are normally distributed (Pallant, 2007).
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Figure 12. Inpatient O2 Oxygen Uptake Distribution

Figure 13. Outpatient O2 Oxygen Uptake Distribution
Paired T-Test was conducted to compare inpatient vs. outpatient of O2 uptake. Average
difference between inpatient and outpatient values (inpatient O2 uptake is higher) equaled 1.73.
There was no significant difference in scores for inpatient (M = 20.99, SD = 6.42) and outpatient
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(M = 19.26, SD 5.28), t value = .94, df = 12, p = .36 (two-tailed). Wilcoxson Signed Rank Test,
non-parametric test of differences, demonstrated no statistical difference between inpatient and
outpatient oxygen (O2) uptake; z = -.839a, p = .40, the median score on the inpatient O2
uptake(Md = 5.58) to post discharge outpatient O2 uptake (Md = 8.21). Despite no statistical
difference between inpatient and outpatient oxygen (O2) uptake scores, the DASI can serve as a
useful role in the follow-up evaluation of patients. Individual results from inpatient to outpatient
DASI scores should be reviewed during the outpatient appointment in order to gauge level of
functional capacity which may aid in establishing various treatment plans along with targeted
risk management to improve prognosis.
Gender. An independent-samples t-test was conducted to compare O2 uptake changes
based on gender. On average, inverse relationship from outpatient vs. inpatient O2 uptake
decreased by 2.3 for females (F = 2.32, SD = 6.69) and males 0.8 (M = .79, SD = 7.24); t value =
.38, df = 11, p = .705 However, this difference between males and females’ change in O2
uptake is not statistically significant. Additionally, t-test of age by gender demonstrated average
age of 5 males in study is 75, 9 females’ average age is 69. Difference between males’ and
females’ ages is not statistically significant (p = .403; two-tailed).
Age. Pearson correlation or Spearman correlation was used to give the direction and
strength of the relationship between variables (Pallant, 2007). A moderate correlation was
detected with age and O2 uptake change from outpatient vs inpatient, (p < 0.05). Additionally,
the distribution of data points suggests a correlation is present when drawing a straight line
through the main cluster of points (Figure XIII). (Pallant, 2007).
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Figure 14. Age vs. Change in O2 Uptake by Gender
An independent-samples t-test was conducted to compare O2 uptake changes based on age.
Average O2 uptake decreased by 7 for patients 70 or under (M = 7.00, SD = 4.82), and increases
by 3 for those over 70 (M = 2.77, SD = 4.19); t = 3.91, df = 11, p = < 0.01. Explanations for
this inverse detection are intriguing suggesting that functional capacity may improve with
increasing age post discharge. These results suggest that older people are potentially benefitting
from the inpatient interventions. The usefulness for clinical decision making regarding lower O2
uptake scores for those under 70 compared those over 70 cannot be explained or understood
given the surprising nature of this result. The fact that other clinical factors are also independent
predictors of functional capacity indicates that an uncomplicated course of inpatient heart failure
designated care is not, in of itself, sufficient to guarantee an optimal functional outcome (Jaeger
et al., 1994). It is, however, an interesting factor to consider in conducting research on HF.
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Five variables and O2 uptake change. Five additional variables were analyzed to determine
if any relationship occurred with O2 uptake change as noted in changes in DASI. There were a
total of 13 patients who completed the inpatient DASI and the 7-10 days post discharge DASI.
The five variables included key items for the pilot program. Independent-samples t-test was
conducted for all five variables as listed to compare O2 uptake changes based on each variable.
a. HF Education: 0 = not fully completed; 1 = fully completed
Three patients were not fully completed (M = .43, SD = 2.64); 10 patients were fully
completed (M = -2.38, SD 7.44); (t (11) = .626, p = .544 [two tailed]). This was not
statistically significant.
b. Teach Back Method: 0 = was not able; 1 = was able
Two patients were unable (M = 7.5, SD = 5.16); 11 patients were able (M = -3.41, SD =
5.49); (t (11) = 2.60, p = .024 [two tailed]). This is statistically higher at p < 0.05.
Especially surprising about this result is that average O2 uptake change of 7.5 for 2
patients who were “unable to teach back” is significantly higher, than average O2 uptake
change of -3.4 for 11 patients who were “able to teach back”. The scores of the 2 patients
that “were unable” went up, while those that “were able”, went down on average.
c. Inpatient Nutrition Consult: 0 = no; 1 = yes
Two patients did not have a nutrition consult completed (M = -.107, SD = 3.49); 11
patients had a consult (M = -2.03, SD = 7.16); (t (11) = .362, p = .724 [two tailed]). This
was not statistically significant.
d. DC Time Out: 0 = not fully completed; 1 = fully completed
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Two patients were incomplete (M =1.34, SD =.22); 11 patients were fully completed (M
= -2.29, SD =7.13); (t (11) = .696, p = .501 [two tailed]). This was not statistically
significant.
e. Follow-up with NP: 0 = no; 1 = yes
Two patients did not see NP (M = 2.15, SD = .304); 11 patients saw NP (M = -2.44, SD =
7.03); (t (11) = .890, p = .393 [two tailed]). This was not statistically significant.
Project Limitations
This project had several limitations. A review of the literature conducted by the author of
this paper found that HF programs often resulted in decreased hospitalizations (Willey, in press).
While most disease management programs for HF seem to work by reducing hospital length of
stay or readmission rates, the impact is not always statistically significant, as noted within this
three month HFPP, and the success of these programs may be a function of the types of patients
enrolled based on the severity of their illnesses (vanVonno, Ozminkowski, Smith, Thomas,
Kelley et al., 2005). In our HFPP, we did not stratify program participants by risk status and
control for differences in co-morbidities; thus, severity of illness varied widely among all pilot
participants. Despite the intricacies involved in adjusting for differences, a comparison group
may be used which remains an option for this CAH to develop and implement with IRB
guidance. Otherwise, it may not be possible to infer whether observed changes are really due to
program participation (vanVonno et al., 2005).
Second, the responses to the questions on the DASI are subjective and may be affected by
patient factors and by method of administration. Given the number of HF nurses, method of
administration will vary. However, in the outpatient setting, the DASI was administrated by the
same individuals: the program facilitator or the program assistant. In addition, the DASI has
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been validated in younger patients, but has not been separately validated in older patients (Jaeger
et al., 1994). One study by Arena, Humphrey, and Peberdy (2002) attempted to assess the
reliability or validity of the DASI in HF population with a small sample size of 33 participants.
Future research is needed to determine if this questionnaire holds value in the HF population
group (Arena, Humphrey, & Peberdy, 2002).
Third, there were scheduling challenges to ensure that a HF nurse care for a HFPP
patients during the inpatient stay. While all HFPP patients had a HF nurse caring from them
while inpatient, there were several shifts when HFPP patients did not have a designated HF nurse
either due to one not working or inability to change assignments to allow a HF designated nurse
to care for a HFPP patient. Clearer scheduling protocols need to occur to allow HF nurses to
care for HFPP patients. While these strategies may require change in assignments, discussions
regarding protocol adherence with the department managers, charge nurses, and HFPP
champions must continue in order to evaluate missed opportunities.
Fourth, given the scope of this HFPP, inclusion criteria applied to patients who were
being discharged home since outpatient cardiology follow-up seemed most likely to occur.
Patients who were transferred to another acute care hospital or extended care facility were
excluded based on potential for loss to follow-up in the outpatient cardiology setting; however,
waivers were granted for the two patients who were transferred to another acute care facility
since they were inadvertently included in the pilot. Both of these patients returned for outpatient
cardiology follow-up and thus deemed to be good candidates for the outpatient pilot program. It
was determined that patients who are transferred to another acute care facility require careful
consideration in terms of follow-up care. Nevertheless, this finding supports the contention that
transferred patients may benefit by being included in the CAH HF pilot program.
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Fifth, seven patients received portions of the inpatient HFPP, but were excluded due to
discharge disposition to a skilled nursing facility (SNF), consideration of this population group is
warranted. Gaps remained in those discharged to SNFs which deserve further attention
regarding inclusion in the HFPP providing follow-up in the outpatient cardiology setting can be
achieved. Furthermore, opportunities exists for nurse case management to develop a follow-up
phone call process within 48 hours of discharge to the registered nurse/licensed practical nurse in
the SNFs to verify or clarify discharge instructions which may improve continuity of care
(Jacobs, 2011). Tracking of the SNF population group requires further tightening should the
program continue. Additionally, it may be beneficial for various SNF patients to receive the
inpatient HFPP despite the likelihood of loss to follow-up. If program adoption occurs,
incorporating this population group warrants additional discussion among all key stakeholders.
Conclusion
The purpose of an evaluation is to learn about the facilitators and barriers to program
implementation. Thus, negative or unexpected results should be viewed as opportunities for
discussions about how to better organize programs, how to run them more effectively, and how
to best work with patients and their providers (vanVonno et al., 2005). An appealing benefit of
conducting an evaluation pilot program is that these discussions can occur prior to full-scale
rollout. Additionally, a pilot study is critical in determining the feasibility of subject enrollment,
the intervention, the protocol or data collection plan for the study, and the likelihood that
subjects will complete follow-up measures (Melnyk & Fineout-Overholt, 2005, p. 266).
What we learned about this pilot program is that it takes a considerable time to
implement and monitor all aspects in order to ensure the protocol is being followed appropriately
by all HF nurses. Discussions with the CAH senior managers will need to be maintained during
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this pilot in order to keep the momentum going with all pilot features including, but not limited
to, communication with unit managers in order to maintain their commitment and full
engagement to this project.
Dissemination of Findings
Results have been shared with key stakeholders at the CAH including all aspects of the
pilot features. Formal presentations occurred at the CAH on April 28, 2011 and on campus at
the University of Massachusetts, Amherst on May 12, 2011. If suitable for publication, the IRB
will be notified to determine status of this pilot.
Program Continuation
Several of these HF interventions have been proven in the literature to lower readmission
rates after HF hospitalization, including improved hospital and post-discharge care, predischarge planning, home-based follow-up, and patient education (Ross et al., 2010). Findings
from this CAH pilot support program continuation. Additional data with a larger sample size
may result in actualization into a formal HF program. Plans for post-project continuation and
implications for future practice and translational research initiatives have been determined by
senior management at the CAH. On April 1, 2011 the CAH Chief Nursing Officer determined
program continuation for an additional three months projecting to end on June 30, 2011.
Heart Failure nurse champions on the 2MS unit and CCU have been selected to assist in
overseeing project protocols along with the aid of the program assistant. The project facilitator
will be available for consultation as needed. The goal of these champions will be to ensure
potential patients are identified and included in the HFPP, and that the three pilot forms are
instituted and fully completed. Results of specific outcome indicators noted in Tables II-V of
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less than 100% have been shared with all project staff and their managers in order to identify
opportunities for improvement.
Additional concerns point to the following:
Considerations to data tracking and entry will be carried-out by the program assistant
with oversight by the program facilitator; follow-up phone calls will be carried-out amongst the
designated HF nurses on 2MS and CCU with oversight by the program facilitator and assistant in
ensuring calls are made within the protocol timeframe.
On two occasions during this HFPP, patients who were transferred to another acute care
facility were inadvertently placed on this pilot despite meeting the exclusion criteria. However,
both patients were deemed appropriate for this HFPP since both patients would eventually be
seen by the NP in the outpatient cardiology department. Therefore, the program facilitator
modified the inclusion criteria for two patients. This particular exclusion as listed in the protocol
may warrant modification with an IRB amendment in order to capture patients who would be
seen for follow-up in the outpatient cardiology office.
In the outpatient setting, the NP has agreed to administer the outpatient DASI and
provide satisfaction questionnaires to program participants. The NP will provide these
documents to the program assistant for data entry. Since the protocol requires a second DASI 710 days post discharge, it will be important for the program assistant to be aware of any patient
who is not scheduled to be seen in the outpatient setting. Communication patterns regarding
protocol adherence requires additional attention for all project staff to ensure discrepancies are
minimized and opportunities for improvements are addressed.
As previously stated, comments derived from 2MS pointed to the overabundance of
paper work during the discharge process which may be displaced and not necessarily due to this
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particular pilot. Should this HF program be adopted this explicit concern should be addressed
with all HF designated nurses and the CAH in order to streamline inpatient HF documentation.
A key aspect of what we learned during this pilot program points to constant vigilance and
frequent reminders with all HF nurses in ensuring HF pilot protocols utilizing evidence-based
care is carried out during the entire admission period. Communication patterns with the project
staff must continue in order to ensure potential HF patients are not missed or that protocol
adherence is not followed properly. Furthermore, extra assistance and guidance in developing
expertise for all nurses in HF care may be warranted should this pilot prove to be effective in
hospital-based outcome measures.
Lastly, should program adoption occur, components for information systems should also
be reviewed for electronic medical record (EMR) purposes specifically in terms of meaningful
use.
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4Q’s - 2010

Figure 1. Critical Access Hospital HF Process Measures Year 2010
Critical Access Hospital (2011, March).
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Figure 2. Critical Access Hospital HF Appropriate Care Score
Critical Access Hospital (2011, March).

2010

TRANSITIONS HOME FOR PATIENTS WITH HEART FAILURE

Figure 3. Critical Access Hospital (CAH) HF 30 Day All-Cause Readmission Rate
Critical Access Hospital (2011, March).
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Figure 4. Appropriate Care Score (ACS) Breakdown
Critical Access Hospital (2011, March).
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DISCHARGE TIME OUT - Heart Failure (HF) Pilot Program
Heart Failure (HF) Specific Considerations / Management Issues
o LVF assessment: Has the patient ever had an ECHO? Y/N
o Submit diet consult through
o ACE or ARB for EF less than 40% - Contraindication
Meditech
documented? Y / N
o Call Nutrition Center: xxxo Beta Blocker for EF less than 40% - Contraindication
xxxx for outpt nutrition
documented? Y / N
appointment
NURSING
o Enhanced admission assessment includes: identification of caregivers for D/C planning &
predicting post hospital needs.
o Duke Activity Status Index (DASI) given to patient and completed shortly after admission
o Determine need for smoking cessation / counseling
o Did the pt. smoke anytime during the 12 mths prior to hospital arrival? Y / N If yes, document
if pt. declined or received smoking cessation counseling.
o Patient/caregiver education completed and documented nurses note utilizing “teach back” &
“Ask me 3” techniques
o Document pt. understanding (or caregiver) of HF disease management in discharge nurses note in
Meditech
o Discharge Instructions must address: physical activity, diet, follow-up, medications, worsening
symptoms, and weight monitoring
o FVH heart failure education packet given to patient / caregiver
o Medication reconciled
o Medication profile reviewed with patient and/or caregiver
o Prescription given to patient/caregiver
o Nursing Home/Home Care referral completed, patient/caregiver given copy for Home Care
o Pnuemovax/flu vaccine given if applicable
o HF out-patient appointment scheduled with Cardiology FNP ___________________
Call Cardiology: ext 9777
o Patient instructed regarding out-patient cardiology appointment
o Patient instructed regarding follow-up blood work, if needed.
o Scale provided to patient and/or caregiver if needed
NOTE: Staple Med Rec and DC Instructions to this form after discharge
“HF” Nurse Name: ________________________Date of Patient Discharge:_______________
Figure 5. DISCHARGE TIME OUT - Heart Failure (HF) Pilot Program

Trial form for HF Pilot Program
2011
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Figure 6. Duke Activity Status Index (DASI) A Self-Administered Questionnaire
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HEART FAILURE PILOT PROGRAM - Patient Teaching
“A Stronger Pump”
Category

Pages

Heart failure

Nurse
providing
education

Patient able
to teach
back?
Yes or No

Patient unable to teach back
(please comment)

2

How you may feel

3-6

Heart failure testing

7-9

Medical treatment

10-17

Surgery for heart
failure
Your role in heart
failure control
In summary

18-20

Causes of heart
failure
Congenital heart
disease
Managing heart
failure at home

32-37

21-30
31

38-39
40

“Stop Light Education”
Category

Nurse
providing
education

Patient able
to teach
back?
Yes or No

Patient unable to teach back
(please comment)

Green Zone
Yellow Zone
Red Zone
Nurse

Initials

Nurse

Initials

Figure 7. HEART FAILURE PILOT PROGRAM - Patient Teaching - “A Stronger Pump”
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HEART FAILURE PILOT PROGRAM - Patient Satisfaction

Your comments and concerns are very important to us. We are
continually trying to improve our heart failure pilot program. Please
take a moment to complete this survey and return it in the provided self
addressed, stamped envelope.
Directions: Please circle the number that corresponds to your rating for
each program part – with 5 being the highest rating and 1 being the
lowest rating. Please provide detailed comments for each area.
A. In-patient Education (Your hospital stay)
13.The education portion was effective in
teaching me new information and
reinforced information I already
knew.
14.The nurses presented the education
material with enthusiasm.
15.The nurses were knowledgeable and
well prepared to present education
material.
16.The education sessions covered all
necessary information and answered
my questions.
Comments:

Very
good

good

fair

poor

Very
poor

5

4

3

2

1

n/a

5

4

3

2

1

n/a

5

4

3

2

1

n/a

5

4

3

2

1

n/a

B. Out-patient Education (In the Cardiology Dept.)
Very
good

17.The education portion was effective in
teaching me new information and
reinforced information I already

5

good

4

fair

3

poor

2

Very
poor

1

n/a
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knew.

18.The nurse practitioner(s) presented the
education material with enthusiasm.
19.The nurse practitioner(s) were
knowledgeable and well prepared to
present education material.
20.The education sessions covered all
necessary information and answered
my questions.
Comments:

C. Facility and Nursing (Overall)
1. All staff provided an appropriate level
customer service.
2. The heart failure program
provided all the information I needed.
3. The facilities are clean and safe.
3. Please rate the overall care you received
during the program.
Comments:

5

4

3

2

1

n/a

5

4

3

2

1

n/a

5

4

3

2

1

n/a

Very
good

good

poor

Very
poor

5

4

3

2

1

n/a

5

4

3

2

1

n/a

5
5

4
4

3
3

2
2

1
1

n/a
n/a

fair

Thank you very much for taking the time to complete this survey.
Figure 8. HEART FAILURE PILOT PROGRAM - Patient Satisfaction
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CAH - HEART FAILURE ROUTINE TELEPHONE CALL
Patient’s Name: ___________________________________Date of call: _________________
ID No.: ___________________________________________Date of D/C: ________________
Cardiologist: _____________________________________ Primary MD: ________________

Telephone Assessment
1. Current symptoms

Chest pain/discomfort

Shortness of breath

Palpitations

Night time SOB

Dizziness

Fatigue

Edema of legs, ankle, & / or abdomen
o Is this a change_______________________________________________________________________
 If any of the above are checked, please page Cardiology NP @ #9739

Weight today: _________________lb
o Change ___________________lb
o Hospital discharge weight:_______________lb
o Initial Home weight:____________________lb
 If patient gains >2lbs/24 hours or 5 lbs in 1 week, please page Cardiology NP @ #9739
o 2000 mg sodium (salt) restriction compliance? ____________________________________________
o Other (specify) _______________________________________________________________________
2. Change in symptoms: Overall, how are your symptoms compared to 2 days ago?

Better 
About the Same  Worse (describe) ________________________________________
o If patient describes symptoms as “worse” please page Cardiology NP @ #9739
3. Current treatments

Medication changes (for CHF)
o Were you able to get all your medications from the pharmacy?
o Any issues with current medications?
o Any questions understanding your medication list?
o Discharge medication profile attached
4. “Can you tell me the name of your water pill?”____________________________________________________
5. “Are you using the stop light visual”? ___________________________________________________________

“Can you tell me what amount of weight gain you should report to your doctor?”________________

“Which doctor would you report those symptoms to?”________________________________________
6. “Have you had an Echocardiogram of your heart recently”?_________________________________________
7. “Have you recently had counseling about stopping smoking”?______________________________________

MANAGEMENT RECOMMENDATIONS / Follow-Up (check all that apply)




Contacted Cardiology, FNP BC re: CHF issues phone extension 9739 or pager #9739
Cardiologist Follow Up Appointment:_______________________________________________________
Primary Care Physician Follow Up Appointment:_____________________________________________

Figure 9. Critical Access HF Routine Telephone Call
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Quoted in Literature

$750
$1400
$93 - 1400
DM Program
$5000
$2500
$2500-14000
HF Hospitalization
$1700
$2700
$680-2700
Annual Outpatient
HF Care
$10000
$13000
$7300-13000
Annual Non-HF
Health Care
Figure 10. Chan and colleagues (2008): Cost Estimates for HFDM Program
A cost-effectiveness analysis (CEA) was performed by Chan and colleagues for disease
management programs enrolling high-risk to baseline-risk patients; standardized to 2005 US
dollars by the consumer price index for health care. Costs for hospitalization were incurred
whenever a patient was hospitalized; also accounted for were yearly outpatient HF costs and
non-HF health care costs (Chan et al., 2008).
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Reference:
United States National Library of Medicine: National Institutes of Health (n.d.). National Information Center on health Services
Research and Health Care Technology (NICHSR). HTA 101: IV. Cost Analysis Methods. Retrieved on 11/17/2010 from
http://www.nlm.nih.gov/nichsr/hta101/ta10106.html

Figure 11. Cost-Effective Analysis (CEA)
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Appendix A
Existing research on Heart Failure (HF) and Disease Management (DM)
Citation
Sample and
Design
Outcomes/Results
location
of the
research/study
intervention
was
and/or objectives
performed
of the study
Inglis et al.,
25 full peerSystematic
Assess the effects
(2010)
reviewed
Review and
of telemonitoring
studies metametaand/or structured
analysed.
analysis
telephone support
programs on: 1.
International
All-cause
mortality, HFrelated admissions,
all cause
readmissions and;
2. Length of stay,
QOL, healthcare
cost savings in
patients with HF
and acceptability
of the intervention
to patients with
HF.

Copeland,
Berg, &
Johnson
(2010)

458 pts
South West,
USA

Prospective
randomized
controlled
design with a
1-year preintervention
data
collection

No differences in
clinical outcomes
were noted
between the
intervention group
(telemedicine
intervention) and
the control group.

Strength(s)
and
weakness(es)

Strength of this
review and
meta-analysis is
that these
researchers
considered and
synthesized
evidence on
almost all
aspects from
which an effect
of these
interventions is
important
(mortality,
hospitalizations,
length of stay,
acceptability,
functional
capacity and
cost).

Evidence
Level

I

Weakness:
Unable to
stratify results
according to
age, functional
class or sex as
outcomes were
not reported in a
manner that
allowed
extraction of
sub-group
specific data.
Strength:
RCT with a 1II
year preintervention
data collection
period and a 1yr intervention
and follow-up

Class

I

IIa
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Taylor et al.,
(2009)

Sixteen trials
involving
1,627 patients
were included.

period and a
1-year
intervention
and followup period.

The HF related
costs were higher
for the intervention
group, as were
overall costs that
included the cost
of the intervention.
Intervention group
patients reported
better compliance
with weight
monitoring and
exercise
recommendations.

Systematic
Review

Effectiveness of
disease
management
interventions for
patients with HF.
Interventions were
classified into
three models.

Hebert et al.,
(Oct. 2008)

Randomly
assigned 406
patients to
usual care (203
patients) or a
nurse-led
program (203
patients) in
which patients
had 1 in-person
visit with a
trained nurse
and periodic
follow-up
telephone calls
over 12

Randomized
Control Trial
(RCT)

Data abstracted
does not allow for
firm
recommendations
for practice.
A nurse-led
disease
management
program for
patients with HF
improved QOL at
an expected cost to
society of less than
$2177 per patient
were more than
offset by reduced
hospital costs of
$2378 per patient,
but higher costs for
outpatient
procedures,
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period.
Weakness:
Intervention
process
measures and
patient-level
details on
numbers of
calls and alerts
were
unavailable for
this study. All,
but 5 patients,
were male.
Results of this
study may not
be generalizable
to non-VA
populations.
Strength:
Objectives and
criteria for
inclusion were
clearly defined.

I

IIb

Weakness:
There was some
overlap between
models with
some
interventions
being difficult
to classify.
Strength:
This is the first
costeffectiveness
analysis for
nurse
management of
HF to include
all
recommended
categories of
cost.
Weakness:
Since the trial
was conducted

II

IIb
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months.

medications, and
home health care
prevented the
intervention from
being cost-saving
over the 12-month
study.

Harlem, NY

Esposito et al.
(2008)

Zile et al.,
(2008)

37,000
beneficiaries in
the Medicare
fee-for service
(FFS) program.
Southern
Florida

Randomized,
intent to treat
design;
over 18
month
period of
program
operations.

70 patients, a
subgroup
analysis of the
COMPASS-HF
Trial (Bourge
et al., (2008).

Randomized
Trial,
Diastolic
heart failure
patients
(DHF)

The LifeMasters
Supported
SelfCare
demonstration
program provides
primarily
telephonic patient
education and
monitoring
services.
Over the first 18
program months,
average Medicare
costs of the
treatment group
were nearly 10
percent lower (p =
0.008) than those
of the control
group among
patients with HF
residing in the
LifeMasters
redesign catchment
area at enrollment.
For Medicare feefor service (FFS)
program,
beneficiaries with
HF who resided in
high-cost South
Florida counties,
the program
reduced Medicare
expenditures by
9.6%.
DHF patients were
randomized to
implantable
hemodynamic
monitor (IHM)
guided care
(treatment) vs.

in an ethnically
diverse, innercity
neighborhood,
these results
may not be
generalized to
other settings.
Strength: Large
sample size,
clear display of
statistical
results.
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II

I

II

IIb

Weakness:
Portions of their
analysis
included other
conditions,
although HF
was extracted
separately for
examination.
Only 35% had
HF even though
it was a primary
target condition
for the
demonstration.

Strength:
Statistical
results
discussed and
clearly
displayed.
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Minneapolis,
Minnesota

Krantz et al.,
(2008)

64 patients
Denver, CO

New York
Heart
Association
(NYHA)
class III or
IV HF pt’s
included.

Randomized
Control Trial

standard care
(control) for 6
months.
Results
demonstrated a
20%
nonsignificant
reduction in the
overall heart
failure-related
events (HFRE)
rate in the
treatment group (p
= .66). IHMguided care did not
result in a
statistically
significant
reduction in HFRE
rate or reduction in
relative risk of a
HFRE in DHF
pt’s.
Study compared 6month
rehospitalization
rates among
patients assigned
to predischarge Bblockade coupled
with postdischarge
nurse management
(intervention)
versus usual care
(control).
Among
intervention
patients at 6months, B-blocker
utilization was
higher (p <.001),
mean NYHA class
improved (p=.01),
and total HF
rehospitalizations
were reduced by
84% (p = .02). A
trend toward
improved LVEF
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Weakness:
The
COMPASS-HF
trial (Bourge et
al., 2008) was
not designed or
powered with a
sufficient
number of DHF
patients to
statistically test
the efficacy of
IHM-guided
management in
DHF patients as
a separate
group.

Strength:
statistical
results clearly
displayed.
Potential
strengths of this
intervention
strategy include
its simplicity
and
generalizability
into a variety of
patient
populations and
health systems.
Weakness:
Small sample
size, vulnerable
population , loss
to follow-up,
and single
center
experience in
CO.

II

I
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Jaarsma et al.,
(2008)

1023 patients
Coordinating
Study
Evaluating
Outcomes of
Advising and
Counseling in
Heart Failure
(COACH)

Randomized
controlled
trial
NYHA
functional
class II to IV
included.

Netherlands

was also observed
(p = .17).
Pt’s were assigned
after HF
hospitalization to 1
of 3 groups:
control group (f/u
by cardiologist)
and 2 intervention
groups with
additional basic or
intensive support
by a nurse
specializing in
management of
pt’s with HF.
Primary findings
do not support the
concept that
adding either a
basic or an
intensive nurse-led
management
program to
standard care of a
cardiologist
reduces the
combined end
point of death or
rehospitalization
because of HF.

Ramachandran 50 patients: 2
et al., (2007)
groups of 25
pt’s each.
India

Prospective,
Randomized
clinical trial

Two groups of 25
pt’s each over six
month study
period. The
control group was
managed in the HF
clinic receiving
usual care, and the
intervention group
underwent
additional
interventions
utilizing
interactive sessions

Strength:
Baseline
characteristics
of the 3 groups
were
comparable.
Large sample
size.
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II

IIb

II

IIa

Weakness:
Limitations
were not clearly
stated.
Explanations
for the absence
of a difference
in the event rate
between the
control and
intervention
groups are that
either patients
in the control
group were
managed well
enough already,
thus making it
difficult to
further improve
outcomes, or
the quality of
the intervention
did not improve
treatment.
Strength: First
report of the
impact of a
comprehensive
telephone-based
HF
management
program in
India.
Weakness:
Small sample
over short
period: 6 mths.
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and telephonic
helpline telephone
calls.

Nguyen et al.,
(2007)

190 patients:
94 in the
experimental
group (HF
management
program) and
96 in the
control group
(standard care).

Randomized
Trial

Montreal,
Canada

There was
significant
improvement in
the QOL and
functional capacity
of patients in the
intervention group
compared with
controls over a 6mth period.
Assessed longterm recurrent ED
visits,
readmissions, and
mortality among
HF patients who
were discharged
after a 6-month
intensive HF
management
program (HFMP).
Study revealed no
sustained longterm benefit
compared to usual
care for severely ill
patients (mostly
NYHA III and IV)
who have just been
discharged from a
successful 6-mth
intensive HFDM
program

Del Sindaco et
al., (2007)

173 patients

Randomized
Trial

Italy
NYHA
functional
class III-IV
included

Aim of the study
was to determine
the long-term
efficacy of a
hybrid disease
management
program (DMP)
involving
interdisciplinary
DM with
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Design and
setting was
specific to the
needs of an
Indian
population.
Limitations to
the study were
not discussed.

Strength:
Despite small
sample, ability
to detect
difference and
large effect was
good, because
of the frequent
occurrence of
the outcome of
interest.
Weakness:
Small sample
size limits
precision; lack
of subgroup
analyses.
Unable to
control for
patient or
physician
variations.
Subject with
NYHA class IIIV only.
Strength:
Baseline
evaluation upon
discharge from
hospital was
discussed.

Weakness:

II

III

II

IIa
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cardiologists,
PCPs, nurses
(intervention
group) and usual
care (control
group) who
received all
treatments and
services ordered
by ther PCPs and
/or cardiologists;
combining preand post-discharge
care and following
patients for 2
years.

Gohler et al.,
(2006)

36 RCT studies
published
between 1993
and 2005 from
13 different
countries with
data from 8341
patients.
Boston, MA
Berlin,

Systematic
Metaanalysis

At a 2-year followup, a 36%
reduction in allcause death and
HF hospital
admissions was
observed in DMP
vs. usual care.
All-cause and HF
admissions as well
as length of
hospital stay were
also reduced. This
study
demonstrated a
hybrid DMP for
elderly HF pt’s
improves
outcomes and is
cost-effective over
a long-term
follow-up.
A meta-analysis
was performed to
systematically
combine the
evidence on the
efficacy of DMPs
in the treatment of
HF.
Findings suggest
that DMPs reduce
all-cause mortality
as well as first and
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Small sample;
Study was
conducted at
specialized HF
clinics, thus
generalizability
of findings to
less specialized
clinical settings
remains
unknown.

Strength:
Analysis was
based on a
larger sample
size and
therefore yields
a more precise
estimate.
Weakness:
Because of the
nature of

I

I
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Germany
Hall, Austria

Nucifora et al., 200 HF
(2006)
patients.

subsequent
hospitalizations in
patients with HF.
This meta-analysis
yielded a pooled
risk difference of
3% (p < .01) for
mortality and of
8% (p < .0001) for
rehospitalization,
both favoring
DMP.

RCT

Italy

Riegel et al.,
(2006)

134
hospitalized
Hispanics with
HF

RCT

Randomized trial
of 200 HF pt’s
discharged from
the hospital to
evaluate the effect
on rehospitalization and
death of a
comprehensive HF
management
program.
Analysis suggests
that the
intervention group
(intensive
education by an
experienced
cardiovascular
research nurse) did
not achieve better
results than the
usual care control
group who
received the
preexisting routine
of post-discharge
care.
Hospitalized
Hispanics with
chronic HF were
enrolled and
randomized to

DMPs, blinding
of patients and
care providers
to the
intervention is
not possible.
Second,
heterogeneity
among included
studies could
only partly be
explained by
covariates.
Also,
intervention
features vary
from one DMP
to another.
Strength:
Patients were
randomized
during
hospitalization,
prior to
discharge.
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II

III

II

III

Weakness:
Small sample
size. Italian HF
management
guidelines from
1998 were
followed.

Strength:
The
intervention
was refined to
be culturally
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intervention
(telephone case
management) or
usual care
(discharge
instructions
provided).

U-Penn
Philadelphia,
PA; San Diego,
CA

Yu et al.,
(2006)

Twenty-one
RCTs
published
between 19952004
Studies
originated in
eight countries
(Australia,
Canada,
Ireland,
Netherlands,
Spain, Sweden,
UK, and USA).

Systematic
Review

No significant
group differences
were found in HF
hospitalizations,
HF readmission
rate, HF days in
the hospital, HF
cost of care, allcause acute care
use or cost,
mortality, healthrelated quality of
life, or depression.
Twenty one trials
were identified
which reported
disease
management
programs (DMPs)
improving the
discharge
outcomes of older
people with heart
failure.
Results indicate
that an effective
DMP should be
multi-faceted and
consist of an inhospital phase of
care, intensive
patient education,
exercise and
psychosocial
counseling, selfcare supportive
strategy,
optimization of
medical regimen,
and ongoing
surveillance and
management of
clinical
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appropriate.
Weakness:
Small sample
size;
Focused solely
on Hispanics
with HF
pointing to a
selective
population
group.

Strenth:
This review
only included
studies that
randomized the
sample and
recruited a
control group.
Weakness:
Sample size
varied
considerably
among the
studies;
studies
evaluated dates
back to 1995;
considerable
variations in
clinical factors
among the 21
reviewed
studies were
noted with
significant
regional
differences in
patient
demographics.

I

I

TRANSITIONS HOME FOR PATIENTS WITH HEART FAILURE

DelgadoPassler &
McCaffrey
(2006)

Roccaforte et
al. (2005)

Five RCT
studies
examined

Thirty-three
RCTs were
included.
Date ranges:
1980-2004
Canada & Italy

Literature
Review

Metaanalysis

deterioration.
The primary
purpose of this
literature review
was to examine
advanced practice
nurse (APN)directed versus
registered nurse
(RN)-directed
telemanagement
programs for heart
failure.
Findings from
three RCT studies
confirmed an APN
role as effective in
improving patient
outcomes in HF
management and
reduce rates of
readmissions.
Aim was to
summarize the
evidence
supporting DMP
effectiveness in
improving HF
clinical outcomes.
RCTs were
included if:
patients were
enrolled with a
diagnosis of HF,
were followed in
an outpatient
setting; a
comprehensive
DMP was
compared to usual
care; all-cause
mortality and/or
(re)hospitalization
rates, and HFrelated
(re)hospitalization
rates and/or HFrelated mortality,
were the outcomes
assessed.
Results

Strength:
Study results
were clearly
displayed.
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IIa

V

Weakness:
Studies were
not metaanalyzed.
Outcome
measures varied
between all five
studies.

Strength:
A sensitivity
analysis was
performed,
stratifying trials
for the quality
components
considered: if
all of them were
present in a
study, the study
was deemed of
“high” quality;
otherwise, it
was judged as
being “not
high”. The
literature search
was
continuously
updated while
the review was
in progress.
Weakness:
It was not
possible to
demonstrate
whether DM

I

I
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Phillips et al.,
(2005)

Seven reports
of six
randomized
clinical trials
selected.
Date ranges:
1966-2004

Metaregression
analysis

Boston &
Baltimore,
USA
The
Netherlands

Ojeda et al.,
(2005)

153 pt’s
discharged
from a
Cardiology
ward – Spain.

RCT,
Prospective
study

demonstrated that
DMP reduced
mortality and
hospitalizations in
HF patients.
Because various
types of DMP
appear to be
similarly effective,
the choice of a
specific program
depends on local
health services
characteristics,
patient population,
and resources
available.
Objectives of this
study were to
determine whether
a hierarchy of
effectiveness exists
with respect to
complexity of
published
protocols of HF
disease
management (DM)
incorporating
specialist nurse-led
HF clinics.
The available
evidence suggests
that specialist
nurse-led HF
clinics are efficient
additions to, or
promising
alternatives for,
HF DM and a very
appealing strategy
for carefully
selected patients.
The objective of
the study was to
evaluate whether
improvements
obtained during an
HF intervention
program were
maintained after
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programs for
HF were
effective in all
clinical settings,
because most
studies included
were performed
in academic,
tertiary, or
urban hospital
centers.

Strength:
Data synthesis
and results was
well described.

I

I

Weakness:
The results
reflect data
from a limited
number of
studies that
were not
powered to
detect changes
in the range of
outcomes
evaluated;
therefore, the
possibility of a
Type II error
cannot be ruled
out.

Strength:
Statistical
II
results were
well displayed
and discussed in
detail. Both
groups were
homogeneous in

IIa
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the program
terms of
stopped.
prevalence of
Patients were
cardiovascular
randomized to
risk factors.
either usual care
Etiology of HF
(control group) or
was similar in
the intervention
control and
group which
intervention
consisted of formal pt’s.
education for
patients and their
Weakness:
families prior to
It is possible
discharge; selfthat these
monitoring of vital results cannot
signs, diet and
be extrapolated
exercise
to all HF pt’s,
counseling, effects since the study
of medications,
only included
and measures to be pt’s DC from
taken in case of
the cardiology
worsening. After
service;
DC, regular f/u
therefore,
visits at the
extrapolation of
outpatient HF
these results to
clinic were
a general
scheduled every 3
population of
months, to assess
pt’s with HF
the pt’s knowledge requires further
of care, to
study. In
optimize medical
addition,
therapy and to
randomization
reinforce the pt’s
of pt’s to either
self-care. Results
continuation or
demonstrated the
withdrawal of
positive effects of
the program,
an intervention
was not done in
program are
this study.
clearly reduced
when it is stopped.
Source of applying classification of recommendations:
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Oates, J. A., et
al. (2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and
Management of Heart Failure in Adults: A Report of the American College of Cardiology
Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collarboration
With the International Society for Heart and Lung Transplantaion. (DOI:
10.1161/CIRCULATIONAHA.109.192065). Retrieved from American Heart Association:
http://www.circ.ahajournals.org
Source for applying level of evidence:
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Melnyk, B., & Fineout-Overholt, E. (2005). Making the Case for Evidence-Based
Practice. In Evidence-Based Practice in Nursing & Healthcare: A Guide to Best Practice (pp. 324). Philadelphia: Lippincott Williams & Wilkins.
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Appendix B
Proposed Inputs and Outputs to the Organizational HF Pilot Proposal
Elements
Human Resources:
Quantity and quality of
personnel: Personnel costs
(New hires, FTEs, hours of
training and education,
biostatistial consulting).

Informational Resources:
Computer hardware and
software – a physical source;
Information
Systems (IS) computer
generated reports.

Monetary Resources:
Funding
Physical Resources:
Material resources, facilities,
and equipment.

Managerial Resources:
Program Manager/Facilitator

Measure of Inputs
1. There were no new
hires for this pilot
program.
2. Designated HF Nurse
on 2MS/CCU will notify
outpt cardiology to
schedule appointment for
HF pt’s with NP, prior to
HF pt’s discharge.
3. Outpt cardiology
receptionist will provide
appointment to
2MS/CCU HF nurse or
charge nurse prior to pt.
discharge.
4. U-Mass biostatistical
consulting
1. During “pilot
program” no upgrading of
hardware or software
occurred.
2. Printing materials for
medical records and or
documents
3. New IS report
capacities may occur after
completion with
information systems (IS)
support.

Amount of grant monies
submitted for program
funding.
1. No new equipment or
facility space was
anticipated for Pilot
Program.
2. Program adoption may
require additional space
for NP, if hired.

1. Education of program
manager and/or facilitator

Measure of Outputs
1. No new employees
2. Number of hours
worked was not
increased due to
scheduling appt. for HF
patients.
3. Providing appt.
day/time is existing
responsibility of
cardiology receptionist
4.Biostatitical
consulting fee at a
student rate.
1. Printing of
tools/forms are
anticipated for data
collection purposes:
Discharge Time Out &
Post-discharge phone
follow-up.
2. After completion of
Pilot Program, adoption
may lead into new
report generation or
electronic medical
record specific for HF
care.
Awaiting determination

1. No changes to
physical resources are
needed for HF Pilot
Program intervention
delivery.

2. Program adoption
may require
additional exam room
1. No additional
managers are

Cost
During pilot –
$60.00/hr student
fee for UMass
statistician
After Pilot
Completion:
Program adoption
may lead to hiring a
designated
cardiology NP.
Estimated salary
with total
compensation
(includes benefit
package) est.
$117,985.92
During pilot –
$5.70 for two
reams of paper.
After Pilot
Completion:
Program adoption
may lead into new
report generation.
Cost currently
undetermined.

No funding or
receipt of grant
monies occurred
During pilot –
$00.00
Program adoption
may require
additional
office/exam room
space. Cost
currently
undetermined.
Program facilitator
estimated volunteer

TRANSITIONS HOME FOR PATIENTS WITH HEART FAILURE
is suitable for pilot;
Program facilitator is a
Doctor of Nursing
Practice (DNPc)
candidate in the Family
Nurse Practitioner Track
(FNPc).

anticipated.

2. Cardio-Pulm RN
assisted facilitator
with inpatient aspects
along with f/u phone
calls post discharge.

2. Additional assistance
and coverage for
facilitator provided by
an RN; cardio-pulm
dept.

Time Resources:

1.Timeline developed,
1.No delay in meeting
presence of deadline for
deadlines
completion available
TOTAL COSTS ANTICIPATED FOR PILOT PROGRAM

114
hours per week:
24-32 hours.
This is “in-kind”,
contributed time.
Calculation to be
determined by
program mentor
and CFO.
Assistance from
cardio-pulm RN
was less than 8 hrs
per week for pilot
program with no
additional cost.
However, if
program is adopted,
designated staff
would need to be
established.
During pilot –
$00.00
$5.70 +
(in-kind amount)

TOTAL COST ANTICIPATED FOR STATISTICAL CONSULTATION

Student fee rate of
$60.00 / hr.

TOTAL COSTS FOR THREE MONTH PILOT PROGRAM

= $185.00
(plus in-kind)

TOTAL COST ANTICIPATED FOR STATISTICAL CONSULTATION
(with Pilot continuation, post doctoral)

$60-$80 per hour
3 hrs anticipated

CARDIO-PULM. RN; increase of 8 hrs per week with pilot continuation.
(Average RN hourly wage: $31.35/hr)
Pilot Continuation for 3 additional mths =

$2,880. (3 mths)

TOTAL COSTS ANTICIPATED FOR PROGRAM ADOPTION

Estimated:
$3,120.
$117,985.92 for
hiring of new NP
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Appendix C
Proposed Inputs and Outputs to the Service Utilization Plan
Elements
Measure of Inputs
Measure of
Cost
Outputs
1. All HF patients who A. Extent to which
During pilot –
Recipients:
Determines the extent to
were discharged home the target audience
$00.00
which the target audience
were included in this
has been reached.
has been reached.
pilot study.
2. HF patients being
discharged to extended
care facilities were
excluded from this
pilot study.
3. HF patients who are
transferred to another
acute care center were
excluded from this
pilot study (1 pt. was
waived).
1. Hospitalists
A. Extent to which
During pilot –
Participants:
Extent of multidisciplinary involvement was
the target audiences $00.00
critical
staff engagement.
has been reached.
Program adoption may
2. Nurses who will
require additional
volunteer in becoming
workshops for nurses
“HF Nurses” and/or
focusing on acute HF
champions for pilot
care. Cost currently
program was critical.
undetermined.
3. Cardiologist
involvement was
Cardiology NP
critical.
involvement may
4. Cardiology NP,
necessitate additional
involvement during
compensation.
outpatient HF patient
Amount undetermined.
visits was critical.
1. Follow-up phone
1. Data collection
During pilot Queuing:
Ability of system to move calls made post
completed for f/u
$00.00
patients through program
discharge within 24-48 phone calls.
hours.

Social Marketing:
Extent of social marketing

2. Out pt. appointment
with cardiology is
scheduled 7-10 days
post discharge
1. Quality and extent
of social marketing

2. Patients are seen
within 7-10 days in
outpatient
cardiology.
1. Multidisciplinary team

During pilot $00.00
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analysis

Intervention:
How well the intervention
was delivered to HF
patients – Consistency of
implementing program

Organization:
How well this pilot was
viewed by stakeholders
and staff.

within the
organization will be
conducted and
maintained by the
program facilitator.
2. Meeting with local
PCPs will be
conducted through the
CAH Medical Staff
Dept.

1. Multi-disciplinary
staff were encouraged
to be supportive of
program interventions
2. Extent of revisions
based on previous
cycle or month of
intervention delivery.

members at the CAH
are aware of pilot
program.
2. Pertinent Council
and/or committee
awareness occurred
in Dec 2010 and Jan
2011.
3. PCPs in the region
were informed of
this pilot program
and ensured their
patients will
continue to followup with them for
continuity in care.
1. Number of hours
for program delivery
will be tracked
2. Number of
participants
completing
intervention (service
completion) will be
tracked.

1. Viewpoints and
1.Administration
participation of
acceptance
administration
2. Hospitalists
1. Viewpoints and
acceptance
participation of
3. Nursing staff
hospitalists and
acceptance
cardiologists
2. Viewpoints and
participation of
nursing staff
TOTAL COSTS ANTICIPATED FOR PILOT PROGRAM
TOTAL COSTS ANTICIPATED FOR PROGRAM ADOPTION
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Program adoption may
require additional
marketing costs –
currently
undetermined.

See Table for cost
benefit analysis

During pilot –
Est. $00.00

$00.00
Undetermined
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